Literature for peptidase C01.032: cathepsin L

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, A Assay, T Target, P Specificity, K Knockout, E Expression, V Review, M Mutation, R Splicing, I Inhibitor, L Localization. To select only the references relevant to a single topic, click the link above. See explanation.)

    2026
  1. Mao,Z., Shen,C., Liang,S., Zhou,T., Li,J., Yang,P., Shi,Q., Guo,Y. and Zhang,X.
    Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine derivatives as cathepsin L inhibitor for the treatment of acute lung injury
    Eur J Med Chem (2026) 303, 118463-118463. PubMed  Europe PubMed DOI
  2. Smith,J.R., Toro,A., Sabater,A., Kovacic,S., Ban,F., Arevalo,A.P., Crispo,M., Gueron,G., Young,R.N. and Cherkasov,A.
    Pharmacokinetics, pathology and efficacy of SARS-CoV-2 main protease inhibitor VPC285785 in a murine model of coronavirus infection
    Sci Rep (2026) 16, 6905-6905. PubMed  Europe PubMed DOI  PMC  EPMC  I
  3. 2025
  4. Alves,N.L.
    Let the CAThepsin L out of the thymus
    Nat Immunol (2025) PubMed  Europe PubMed DOI
  5. Balta,D., Varghese,A., Prieto Huarcaya,S., Di Spiezio,A., Marques,A.R.A., Akdas,E.Y., Tabakacilar,D., Drobny,A., Werner,C., Xiang,W., Machtel,R., Dobert,J.P., Fejtova,A., Richter,F., Kuspert,M., Arnold,P., Saftig,P. and Zunke,F.
    Recombinant cathepsins B and L promote alpha-synuclein clearance and restore lysosomal function in human and murine models with alpha-synuclein pathology
    Mol Neurodegener (2025) 20, 95-95. PubMed  Europe PubMed DOI  PMC  EPMC
  6. Chen,Y., Shi,Y., Zuo,X., Dong,X., Xiao,X., Chen,L., Xiang,Z., Ren,L., Zhou,Z., Wei,W., Lei,X. and Wang,J.
    UNC0638 inhibits SARS-CoV-2 entry by blocking cathepsin L maturation
    J Virol (2025) , e0074125-e0074125. PubMed  Europe PubMed DOI  K
  7. Cui,Z., Liu,T., Bacon,R., Zhao,Y., Everitt,J.I., Yan,J., Chen,L., Huang,J., Wang,H., Dong,Y., Jin,V.X., Liu,S.L. and Wang,Q.
    Single-dose cathepsin L CRISPR nanotherapy mitigates PASC-like lung damage in hamsters
    Nano Res (2025) 18 PubMed  Europe PubMed DOI  PMC  EPMC
  8. Ding,Y., Zhang,H., Wang,X., Tan,J., Wang,M., Chen,Y., Safia,I.H., Zhu,G., Zhang,X. and Liu,Y.
    Targeting lysosomal protease CTSL promotes anti-tumor immunity and sensitizes HNSCC to PD-1 blockade by stabilizing PDK1 and activating Akt-PD-L1 axis
    Neoplasia (2025) 69, 101228-101228. PubMed  Europe PubMed DOI  PMC  EPMC
  9. Enneking,A.E., Khorey,M.M. and Edgington-Mitchell,L.E.
    Nuclear Roles for Canonically Lysosomal Proteases
    Mol Cell Biol (2025) 45, 343-352. PubMed  Europe PubMed DOI
  10. Goto,A., Omori,K., Yamaguchi-Tomikawa,T., Kobayashi,H., Shinoda-Ito,Y., Hirai,K., Ikeda,A. and Takashiba,S.
    Interleukin-6/soluble IL-6 receptor-induced secretion of cathepsin B and L from human gingival fibroblasts is regulated by caveolin-1 and ERK1/2 pathways
    Front Dent Med (2025) 6, 1547222-1547222. PubMed  Europe PubMed DOI  PMC  EPMC
  11. Guo,K., You,B., Zhou,W., Li,Y., Wang,Z., Zhang,J. and Si,S.
    Fluorescence Polarization-Based High-Throughput Screening Assay for Inhibitors Targeting Cathepsin L
    Bio Protoc (2025) 15, e5400-e5400. PubMed  Europe PubMed DOI  PMC  EPMC  A
  12. Guo,L., Zhang,B., Cui,X., Wang,X., Xiao,J., Miao,S., Song,K. and Sun,J.
    USP20 competitively binds to STUB1 to enhance CTSL expression and promote epithelial-mesenchymal transition in head and neck squamous cell carcinoma
    Clin Transl Med (2025) 15, e70520-e70520. PubMed  Europe PubMed DOI  PMC  EPMC
  13. Han,Y., Li,N., Zhao,Y., Jin,Z., Lv,B., Shen,D., Chen,X., Weng,Q., Zhang,M., Chen,K., Dong,L., Liu,Z., Lou,J., Gao,S., Wang,Y., Hua,W., Yan,F., Ying,S., Wu,Y., Chen,Z. and Li,W.
    Lysosomal acidity and cathepsin L activate eosinophils via ARG1-mediated arginine metabolism in allergic airway inflammation
    Nat Commun (2025) 16, 10451-10451. PubMed  Europe PubMed DOI  PMC  EPMC
  14. Juliano,M.A., Persico,M., Severino,B., Tumbarello,G., Okamoto,D., Fernandes,K.R., Trigo,G., Tanaka,A.S., Lacerda,J.T., Tkachuck,O., Corvino,A., Fiorino,F., Scognamiglio,A., Frecentese,F., Santagada,V., Vertuccio,S., Caliendo,G., Juliano,L. and Fattorusso,C.
    1,2,4-Thiadiazolidin-3,5-Diones as Inhibitors of Cysteine Proteases
    Molecules (2025) 30 PubMed  Europe PubMed DOI  PMC  EPMC  I
  15. Kumar,V., Zhu,J., Chenna,B.C., Hoffpauir,Z.A., Rademacher,A., Rogers,A.M., Tseng,C.T., Drelich,A., Farzandh,S., Lamb,A.L. and Meek,T.D.
    Dual Inhibitors of SARS-CoV-2 3CL Protease and Human Cathepsin L Containing Glutamine Isosteres Are Anti-CoV-2 Agents
    J Am Chem Soc (2025) PubMed  Europe PubMed DOI  I
  16. Li,Z., Peluffo,G., Stevens,L.E., Qiu,X., Seehawer,M., Tawawalla,A., Huang,X.Y., Egri,S.B., Raval,S., McFadden,M., D'Santos,C.S., Papachristou,E., Kingston,N.L., Nishida,J., Evans,K.E., Seo,J.H., Clement,K., Temko,D., Ekram,M., Li,R., Rees,M.G., Ronan,M.M., Roth,J.A., Simeonov,A., Kales,S.C., Rai,G., Lal-Nag,M., Maloney,D.J., Jadhav,A., Michor,F., Meissner,A., Balko,J.M., Carroll,J.S., Freedman,M.L., Jaffe,J.D., Papanastasiou,M., Long,H.W. and Polyak,K.
    KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage
    Nat Genet (2025) 57, 1463-1477. PubMed  Europe PubMed DOI  PMC  EPMC
  17. Lumi Tanaka Dino,C., Maria Cavalli,B., Konzen Klein,C., Paes Gomes da Silva,F., Henrique Borges,N., Catharina Joaquim,A., Rodrigues Dos Santos,T., de Araujo,N., Baena Cartens,L., Simoes Florido Almeida,A.C., Nagashima,S., Busatta Vaz De Paula,C., Machado-Souza,C., de Noronha,L. and Bordignon Nogueira,M.
    Placental infection by SARS-CoV-2: exploring alternative entry pathways
    Tissue Barriers (2025) , 2585246-2585246. PubMed  Europe PubMed DOI
  18. Modenbach,J.M., Moller,C., Asgarbeik,S., Geist,N., Rimkus,N., Dorr,M., Wolfgramm,H., Steil,L., Susemihl,A., Graf,L., Schmoker,O., Bottcher,D., Hammer,E., Glaubitz,J., Lammers,M., Delcea,M., Volker,U., Aghdassi,A.A., Lerch,M.M., Weiss,F.U., Bornscheuer,U.T. and Sendler,M.
    Biochemical analyses of cystatin-C dimers and cathepsin-B reveals a trypsin-driven feedback mechanism in acute pancreatitis
    Nat Commun (2025) 16, 1702-1702. PubMed  Europe PubMed DOI  PMC  EPMC
  19. Ntemafack,A., Dzelamonyuy,A., Nchinda,G. and Bopda Waffo,A.
    Mapping Immunological, Host Receptor Binding Determinants, and Cathepsin Cleavage Site of EBOV Glycoprotein Utilizing the Qubevirus Platform
    ACS Omega (2025) 10, 14283-14295. PubMed  Europe PubMed DOI  PMC  EPMC
  20. Paliwal,P., Desai,D. and Datta,M.
    Novel selective and sensitive electrochemical sensor for detection of ovarian cancer biomarker, Cathepsin L
    Bioelectrochemistry (2025) 162, 108856-108856. PubMed  Europe PubMed DOI
  21. Park,S.Y., Son,K., Kim,J., Kim,K., Joo,S., Kim,B., Lee,M., Kim,W., Jung,W.J., Choi,B.K., Jeon,N., Chung,W.Y., Hu,Y., Lee,H. and Song,N.Y.
    Cathepsin L as a dual-target to mitigate muscle wasting while enhancing anti-tumor efficacy of anti-PD-L1
    Nat Commun (2025) 16, 10706-10706. PubMed  Europe PubMed DOI  PMC  EPMC
  22. Petrozziello,E., Sayed,A., Freitas,J.A., Federle,C., Nedjic,J., Ravens,S., Akcabozan,B., Schulz,A.M., Zehn,D., Schmidt-Supprian,M., Obst,R., Prinz,I., Verdoes,M., Kisielow,J., Reinheckel,T., Straub,T., Daley,S.R. and Klein,L.
    Cathepsin L-dependent positive selection shapes clonal composition and functional fitness of CD4(+) T cells
    Nat Immunol (2025) PubMed  Europe PubMed DOI
  23. Porzberg,M.R.B., Groenewold,G.J.M., Lyoo,H., Jakob,A.K.M.H., Titulaer,W.H.C., Cavina,L., Poelaert,K.C.K., Zwaagstra,M., Dieteren,C.E.J., Lemmers,J.G.H., Hamdani,S.H., van Buuren,B.N.M., Ackerschott,B., Platteeuw,J., Michorius,J., Martina,B.E.E., Feiters,M.C., Girones,D., van Kuppeveld,F.J.M., van Hemert,M.J. and Rutjes,F.P.J.T.
    Peptidomimetic Phenoxymethyl Ketone Warheads as Potent Dual-Mode Inhibitors against SARS-CoV-2 M(pro) and Cathepsin
    J Med Chem (2025) PubMed  Europe PubMed DOI  I
  24. Rocha,C., Arora,P., Zhang,L., Sidarovich,A., Graichen,L., Moldenhauer,A.S., Pohlmann,S. and Hoffmann,M.
    Amino acid residues 655 and 969 in the spike protein of Omicron subvariant BA.1 control use of TMPRSS2 versus Cathepsin L dependent entry pathways and cell tropism
    PLoS ONE (2025) 20, e0328879-e0328879. PubMed  Europe PubMed DOI  PMC  EPMC
  25. Sa Magalhaes Serafim,M., Kronenberger,T., Francisco,K.R., de Sousa Reis,E.V., Goncalves de Oliveira,E., Marcelino E Oliveira, Serraglio Fortes,I., Maciel Fernandes,T.H., Barbosa da Silva,E., Fajtova,P., Skinner,D.E., Syed,R.O., Lage de Siqueira-Neto,J., Poso,A., Fernandes Mota,B.E., Alves Coelho-Dos-Reis,J.G., Santos Abrahao,J., Goncalves Maltarollo,V., O'Donoghue,A.J. and Caffrey,C.R.
    Discovery of benzyl carbamate inhibitors of coronavirus M(pro) enzymes from a legacy collection of cysteine protease inhibitors
    J Enzyme Inhib Med Chem (2025) 40, 2585619-2585619. PubMed  Europe PubMed DOI  PMC  EPMC
  26. Xiao,W., Xiong,Y., Wang,Y., Li,T., Chen,C., Shi,Y., Su,G., Zhou,Y., Xiao,S. and Fang,L.
    Cathepsin L and transmembrane serine protease 11E mediate trypsin-independent entry of porcine deltacoronavirus into Huh7 cells
    J Virol (2025) , e0105525-e0105525. PubMed  Europe PubMed DOI
  27. 2024
  28. Bestle,D., Bittel,L., Werner,A.D., Kamper,L., Dolnik,O., Krahling,V., Steinmetzer,T. and Bottcher-Friebertshauser,E.
    Novel proteolytic activation of Ebolavirus glycoprotein GP by TMPRSS2 and cathepsin L at an uncharted position can compensate for furin cleavage
    Virus Res (2024) 347, 199430-199430. PubMed  Europe PubMed DOI  K
  29. Bolsinger,M.M., Drobny,A., Wilfling,S., Reischl,S., Krach,F., Moritz,R., Balta,D., Hehr,U., Sock,E., Bleibaum,F., Hanses,F., Winner,B., Huarcaya,S.P., Arnold,P. and Zunke,F.
    SARS-CoV-2 Spike Protein Induces Time-Dependent CTSL Upregulation in HeLa Cells and Alveolarspheres
    J Cell Biochem (2024) , e30627-e30627. PubMed  Europe PubMed DOI
  30. Chiang,Y.R., Lin,H.T., Chang,C.W., Lin,S.M. and Lin,J.H.
    Dynamic expression of cathepsin L in the black soldier fly (Hermetia illucens) gut during Escherichia coli challenge
    PLoS ONE (2024) 19, e0298338-e0298338. PubMed  Europe PubMed DOI  PMC  EPMC
  31. Ciaglia,T., Vestuto,V., Di Sarno,V., Musella,S., Smaldone,G., Di Matteo,F., Napolitano,V., Miranda,M.R., Pepe,G., Basilicata,M.G., Novi,S., Capolupo,I., Bifulco,G., Campiglia,P., Gomez-Monterrey,I., Snoeck,R., Andrei,G., Manfra,M., Ostacolo,C., Lauro,G. and Bertamino,A.
    Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization
    Eur J Med Chem (2024) 266, 116128-116128. PubMed  Europe PubMed DOI  I
  32. Deng,W., Hu,X., Tian,X., Zhang,Y., Shang,W., Zhang,L. and Shang,L.
    Peptidomimetic Analogues Act as Effective Inhibitors against SARS-CoV-2 by Blocking the Function of Cathepsin L
    J Med Chem (2024) 67, 17124-17143. PubMed  Europe PubMed DOI  I
  33. Falke,S., Lieske,J., Herrmann,A., Loboda,J., Karnicar,K., Gunther,S., Reinke,P.Y.A., Ewert,W., Usenik,A., Lindic,N., Sekirnik,A., Dretnik,K., Tsuge,H., Turk,V., Chapman,H.N., Hinrichs,W., Ebert,G., Turk,D. and Meents,A.
    Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors
    J Med Chem (2024) 67, 7048-7067. PubMed  Europe PubMed DOI  I
  34. Gallwitz,L., Bleibaum,F., Voss,M., Schweizer,M., Spengler,K., Winter,D., Zophel,F., Muller,S., Lichtenthaler,S., Damme,M. and Saftig,P.
    Cellular depletion of major cathepsin proteases reveals their concerted activities for lysosomal proteolysis
    Cell Mol Life Sci (2024) 81, 227-227. PubMed  Europe PubMed DOI  PMC  EPMC
  35. He,Q., Zhao,M.M., Li,M.J., Li,X.Y., Jin,J.M., Feng,Y.M., Zhang,L., Huang,W.J., Yang,F. and Yang,J.K.
    Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality
    elife (2024) 13 PubMed  Europe PubMed DOI  PMC  EPMC
  36. Jangra,S., Raghav,N., Wadhwa,D., Kumar,A., Bhattacharyya,S., Kumar,V. and Sheokand,J.
    Biological evaluation of trans-2,3-dihydrofuro[3,2-c]coumarins as potential cathepsin inhibitors and anticancer agents
    J Biomater Sci Polym Ed (2024) , 1-19. PubMed  Europe PubMed DOI  I
  37. Kakizaki,M., Hashimoto,R., Nagata,N., Yamamoto,T., Okura,T., Katoh,H., Kitai,Y., Akahori,Y., Shirato,K., Ryo,A., Takayama,K. and Takeda,M.
    The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids
    J Virol (2024) , e0185324-e0185324. PubMed  Europe PubMed DOI
  38. Kim,M.J., Kim,S., Reinheckel,T. and Krainc,D.
    Inhibition of cysteine protease cathepsin Lincreases the level and activity of lysosomal glucocerebrosidase
    JCI Insight (2024) 9 PubMed  Europe PubMed DOI  PMC  EPMC
  39. Lu,J., Liang,J., Xiao,G., He,Z., Yu,G., Zhang,L., Cai,C., Yi,G. and Xie,J.
    Cathepsin L in Lung Adenocarcinoma: Prognostic Significance and Immunotherapy Response Through a Multi Omics Perspective
    Cancer Inform (2024) 23, 11769351241307492-11769351241307492. PubMed  Europe PubMed DOI  PMC  EPMC
  40. Mao,L., Shaabani,N., Zhang,X., Jin,C., Xu,W., Argent,C., Kushnareva,Y., Powers,C., Stegman,K., Liu,J., Xie,H., Xu,C., Bao,Y., Xu,L., Zhang,Y., Yang,H., Qian,S., Hu,Y., Shao,J., Zhang,C., Li,T., Li,Y., Liu,N., Lin,Z., Wang,S., Wang,C., Shen,W., Lin,Y., Shu,D., Zhu,Z., Kotoi,O., Kerwin,L., Han,Q., Chumakova,L., Teijaro,J., Royal,M., Brunswick,M., Allen,R., Ji,H., Lu,H. and Xu,X.
    Olgotrelvir, a dual inhibitor of SARS-CoV-2 M(pro) and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19
    Med (2024) 5, 169-171. PubMed  Europe PubMed DOI  I
  41. Mao,L., Shaabani,N., Zhang,X., Jin,C., Xu,W., Argent,C., Kushnareva,Y., Powers,C., Stegman,K., Liu,J., Xie,H., Xu,C., Bao,Y., Xu,L., Zhang,Y., Yang,H., Qian,S., Hu,Y., Shao,J., Zhang,C., Li,T., Li,Y., Liu,N., Lin,Z., Wang,S., Wang,C., Shen,W., Lin,Y., Shu,D., Zhu,Z., Kotoi,O., Kerwin,L., Han,Q., Chumakova,L., Teijaro,J., Royal,M., Brunswick,M., Allen,R., Ji,H., Lu,H. and Xu,X.
    Olgotrelvir, a dual inhibitor of SARS-CoV-2 M(pro) and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19
    Med (2024) 5, 42-61. PubMed  Europe PubMed DOI  I
  42. Matouskova,Z., Orsaghova,K., Srb,P., Pytelkova,J., Kukacka,Z., Busa,M., Hajdusek,O., Sima,R., Fabry,M., Novak,P., Horn,M., Kopacek,P. and Mares,M.
    An Unusual Two-Domain Thyropin from Tick Saliva: NMR Solution Structure and Highly Selective Inhibition of Cysteine Cathepsins Modulated by Glycosaminoglycans
    Int J Mol Sci (2024) 25 PubMed  Europe PubMed DOI  PMC  EPMC
  43. Matsuki,A., Watanabe,Y., Hashimoto,S., Hoshino,A. and Matoba,S.
    Cathepsin L prevents the accumulation of alpha-synuclein fibrils in the cell
    Genes Cells (2024) 29, 328-336. PubMed  Europe PubMed DOI
  44. Moller,C., Rimkus,N., Skala,F.F.O., Merouze,M., Bottcher,D., Dorr,M. and Bornscheuer,U.T.
    Improved recombinant expression of soluble cathepsin B and L in Escherichia coli
    Appl Microbiol Biotechnol (2024) 108, 536-536. PubMed  Europe PubMed DOI  PMC  EPMC
  45. Oliveira,B.R., Nehlmeier,I., Kempf,A.M., Venugopalan,V., Rehders,M., Ceniza,M.E.P., Cavalcanti,P.A.T.P., Hoffmann,M., Pohlmann,S. and Brix,K.
    Cytoskeletal beta-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y
    Biochimie (2024) 226, 49-61. PubMed  Europe PubMed DOI
  46. Park,J.Y. and Park,K.M.
    Recent discovery of natural substances with cathepsin L-inhibitory activity for cancer metastasis suppression
    Eur J Med Chem (2024) 277, 116754-116754. PubMed  Europe PubMed DOI  V
  47. Peng,Z., Luo,X.Y., Li,X., Li,Y., Wu,Y., Tian,Y., Pan,B., Petrovic,A., Kosanovic,D., Schermuly,R.T., Ruppert,C., Gunther,A., Zhang,Z., Qiu,C., Li,Y., Pu,J., Li,X. and Chen,A.F.
    Cathepsin L Promotes Pulmonary Hypertension via BMPR2/GSDME-Mediated Pyroptosis
    Hypertension (2024) 81, 2430-2443. PubMed  Europe PubMed DOI
  48. Previti,S., Ettari,R., Calcaterra,E., Roggia,M., Natale,B., Weldert,A.C., Muller-Ruttloff,C., Salisch,F., Irto,A., Cigala,R.M., Ziebuhr,J., Schirmeister,T., Cosconati,S. and Zappala,M.
    Identification of Dual Inhibitors Targeting Main Protease (M(pro)) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents
    ACS Med Chem Lett (2024) 15, 602-609. PubMed  Europe PubMed DOI  PMC  EPMC
  49. Stuart,S., Tarade,D. and Ohh,M.
    Cathepsins L and B target HIF1alpha for oxygen-independent proteolytic cleavage
    Sci Rep (2024) 14, 14799-14799. PubMed  Europe PubMed DOI  PMC  EPMC
  50. Wu,Y., Jiang,D., Liu,Q., Yan,S., Liu,X., Wu,T., Sun,W. and Li,G.
    Cathepsin L induces cellular senescence by upregulating CUX1 and p16(INK4a)
    Aging (Albany NY) (2024) 16 PubMed  Europe PubMed DOI
  51. Xie,X., Lan,Q., Zhao,J., Zhang,S., Liu,L., Zhang,Y., Xu,W., Shao,M., Peng,J., Xia,S., Zhu,Y., Zhang,K., Zhang,X., Zhang,R., Li,J., Dai,W., Ge,Z., Hu,S., Yu,C., Wang,J., Ma,D., Zheng,M., Yang,H., Xiao,G., Rao,Z., Lu,L., Zhang,L., Bai,F., Zhao,Y., Jiang,S. and Liu,H.
    Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1
    Signal Transduct Target Ther (2024) 9, 54-54. PubMed  Europe PubMed DOI  PMC  EPMC  I
  52. Xu,B., Anderson,B.M., Mountford,S.J., Thompson,P.E., Mintern,J.D. and Edgington-Mitchell,L.E.
    Cathepsin X deficiency alters the processing and localisation of cathepsin L and impairs cleavage of a nuclear cathepsin L substrate
    Biol Chem (2024) 405, 351-365. PubMed  Europe PubMed DOI
  53. Yang,H., Zhou,J.N., Zhang,X.M., Ling,D.D., Sun,Y.B., Li,C.Y., Zhou,Q.Q., Shi,G.N., Wang,S.H., Lin,X.S., Fan,T., Wang,H.Y., Zeng,Q., Jia,Y.L., Xi,J.F., Jin,Y.G., Pei,X.T. and Yue,W.
    Nanoengineered Red Blood Cells Loaded with TMPRSS2 and Cathepsin L Inhibitors Block SARS-CoV-2 Pseudovirus Entry into Lung ACE2(+) Cells
    Adv Mater (2024) , e2310306-e2310306. PubMed  Europe PubMed DOI
  54. Zhang,K., Xu,R., Zheng,L., Zhang,H., Qian,Z., Li,C., Xue,M., He,Z., Ma,J., Li,Z., Chen,L., Ma,R. and Yao,B.
    Elevated N-glycosylated cathepsin L impairs oocyte function and contributes to oocyte senescence during reproductive aging
    Aging Cell (2024) , e14397-e14397. PubMed  Europe PubMed DOI  K
  55. Zhang,Z., Wang,J., Shi,Y., Wang,B. and Wang,D.
    Cathepsin L promotes oesophageal squamous cell carcinoma development and may be associated with tumour-associated macrophages
    Heliyon (2024) 10, e29273-e29273. PubMed  Europe PubMed DOI  PMC  EPMC
  56. Zhou,W., You,B., Zhao,X., Si,S., Li,Y. and Zhang,J.
    Establishment, optimization and validation of a fluorescence polarization-based high-throughput screening assay targeting cathepsin L inhibitors
    SLAS Discov (2024) 29, 100153-100153. PubMed  Europe PubMed DOI  I
  57. Zhou,W., You,B., Zheng,Y., Si,S., Li,Y. and Zhang,J.
    Expression, purification, and biological activity evaluation of cathepsin L in mammalian cells
    Biosci Biotechnol Biochem (2024) 88, 405-411. PubMed  Europe PubMed DOI
  58. 2023
  59. Abdelaziz,R.F., Hussein,A.M., Kotob,M.H., Weiss,C., Chelminski,K., Stojanovic,T., Studenik,C.R. and Aufy,M.
    Enhancement of Radiation Sensitivity by Cathepsin L Suppression in Colon Carcinoma Cells
    Int J Mol Sci (2023) 24 PubMed  Europe PubMed DOI  PMC  EPMC
  60. Doijen,J., Temmerman,K., Van den Eynde,C., Diels,A., Van den Broeck,N., Van Gool,M., Heo,I., Jaensch,S., Zwaagstra,M., Diosa Toro,M., Chiu,W., De Jonghe,S., Leyssen,P., Bojkova,D., Ciesek,S., Cinatl,J., Verschueren,L., Buyck,C., van Kuppeveld,F., Neyts,J., Van Loock,M. and Van Damme,E.
    Identification of Z-Tyr-Ala-CHN(2), a Cathepsin L Inhibitor with Broad-Spectrum Cell-Specific Activity against Coronaviruses, including SARS-CoV-2
    Microorganisms (2023) 11 PubMed  Europe PubMed DOI  PMC  EPMC  I
  61. Ezz,M.A., Takahashi,M., Rivera,R.M. and Balboula,A.Z.
    Cathepsin L regulates oocyte meiosis and preimplantation embryo development
    Cell Prolif (2023) , e13526-e13526. PubMed  Europe PubMed DOI
  62. Fernandez-de-la-Pradilla,A., Royo,S., Schirmeister,T., Barthels,F., Swiderek,K., Gonzalez,F.V. and Moliner,V.
    Impact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin L
    ACS Catal (2023) 13, 13354-13368. PubMed  Europe PubMed DOI  PMC  EPMC
  63. Grozdanic,M., Sobotic,B., Biasizzo,M., Sever,T., Vidmar,R., Vizovisek,M., Turk,B. and Fonovic,M.
    Cathepsin L-mediated EGFR cleavage affects intracellular signalling pathways in cancer
    Biol Chem (2023) 405, 283-296. PubMed  Europe PubMed DOI
  64. Huang,H., Zhang,Y., Xu,X., Liu,Y., Zhao,J., Ma,L., Lei,J., Ge,W., Li,N., Ma,E., Li,Y. and Yuan,L.
    Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells
    Bioorg Med Chem Lett (2023) 80, 129087-129087. PubMed  Europe PubMed DOI  I
  65. Kondo,Y., Rajapakse,S. and Ogiwara,K.
    Involvement of cathepsin L in the degradation and degeneration of postovulatory follicle of the medaka ovarydagger
    Biol Reprod (2023) 109, 904-917. PubMed  Europe PubMed DOI
  66. Li,Y., Wang,K., Sun,H., Wu,S., Wang,H., Shi,Y., Li,X., Yan,H., Yang,G., Wu,M., Li,Y., Ding,X., Si,S., Jiang,J., Du,Y., Li,Y. and Hong,B.
    Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2
    Antiviral Res (2023) 214, 105606-105606. PubMed  Europe PubMed DOI  PMC  EPMC  I
  67. Mouawad,J.E., Sharma,S., Renaud,L., Pilewski,J.M., Nadig,S.N. and Feghali-Bostwick,C.
    Reduced Cathepsin L Expression and Secretion into the Extracellular Milieu Contribute to Lung Fibrosis in Systemic Sclerosis
    Rheumatology (Oxford) (2023) 62, 1306-1316. PubMed  Europe PubMed DOI
  68. Tang,T.T., Li,S.M., Pan,B.W., Xiao,J.W., Pang,Y.X., Xie,S.X., Zhou,Y., Yang,J. and Wei,Y.
    Identification of Flavonoids from Scutellaria barbata D. Don as Inhibitors of HIV-1 and Cathepsin L Proteases and Their Structure-Activity Relationships
    Molecules (2023) 28 PubMed  Europe PubMed DOI  PMC  EPMC  I
  69. Tusar,L., Loboda,J., Impens,F., Sosnowski,P., Van Quickelberghe,E., Vidmar,R., Demol,H., Sedeyn,K., Saelens,X., Vizovisek,M., Mihelic,M., Fonovic,M., Horvat,J., Kosec,G., Turk,B., Gevaert,K. and Turk,D.
    Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins
    Commun Biol (2023) 6, 450-450. PubMed  Europe PubMed DOI  PMC  EPMC
  70. Wang,C., Ye,X., Ding,C., Zhou,M., Li,W., Wang,Y., You,Q., Zong,S., Peng,Q., Duanmu,D., Chen,H., Sun,B. and Qiao,J.
    Two Resveratrol Oligomers Inhibit Cathepsin L Activity to Suppress SARS-CoV-2 Entry
    J Agric Food Chem (2023) 71, 5535-5546. PubMed  Europe PubMed DOI  PMC  EPMC  I
  71. 2022
  72. Denamur,S., Chazeirat,T., Maszota-Zieleniak,M., Vives,R.R., Saidi,A., Zhang,F., Linhardt,R.J., Labarthe,F., Samsonov,S.A., Lalmanach,G. and Lecaille,F.
    Binding of heparan sulfate to human cystatin C modulates inhibition of cathepsin L: Putative consequences in mucopolysaccharidosis
    Carbohydr Polym (2022) 293, 119734-119734. PubMed  Europe PubMed DOI
  73. Gaikwad,P. and Kemp,M.G.
    Cathepsin L inhibition prevents the cleavage of multiple nuclear proteins upon lysis of quiescent human cells
    MicroPubl Biol (2022) 2022 PubMed  Europe PubMed DOI  PMC  EPMC
  74. Islam,M.I., Nagakannan,P., Shcholok,T., Contu,F., Mai,S., Albensi,B.C., Del Bigio,M.R., Wang,J.F., Sharoar,M.G., Yan,R., Park,I.S. and Eftekharpour,E.
    Regulatory role of cathepsin L in induction of nuclear laminopathy in Alzheimer's disease
    Aging Cell (2022) 21, e13531-e13531. PubMed  Europe PubMed DOI
  75. Kladnik,J., Dolinar,A., Kljun,J., Perea,D., Grau-Exposito,J., Genesca,M., Novinec,M., Buzon,M.J. and Turel,I.
    Zinc pyrithione is a potent inhibitor of PL(Pro) and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
    J Enzyme Inhib Med Chem (2022) 37, 2158-2168. PubMed  Europe PubMed DOI  PMC  EPMC
  76. Kwon,C.W., Yeo,S. and Chang,P.S.
    Characterization and molecular docking study of cathepsin L inhibitory peptides (SnuCalCpIs) from Calotropis procera R. Br
    Sci Rep (2022) 12, 5825-5825. PubMed  Europe PubMed DOI  PMC  EPMC  I
  77. Li,C., Liu,Z., Chen,M., Zhang,L., Shi,R. and Zhong,H.
    Critical Role of Cathepsin L/V in Regulating Endothelial Cell Senescence
    Biology (Basel) (2022) 12 PubMed  Europe PubMed DOI  PMC  EPMC
  78. Meewan,I., Kattoula,J., Kattoula,J.Y., Skinner,D., Fajtova,P., Giardini,M.A., Woodworth,B., McKerrow,J.H., Lage de Siqueira-Neto,J., O'Donoghue,A.J. and Abagyan,R.
    Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L
    Pharmaceuticals (Basel) (2022) 15 PubMed  Europe PubMed DOI  PMC  EPMC  I
  79. Mondal,S., Chen,Y., Lockbaum,G.J., Sen,S., Chaudhuri,S., Reyes,A.C., Lee,J.M., Kaur,A.N., Sultana,N., Cameron,M.D., Shaffer,S.A., Schiffer,C.A., Fitzgerald,K.A. and Thompson,P.R.
    Dual Inhibitors of Main Protease (M(Pro)) and Cathepsin L as Potent Antivirals against SARS-CoV2
    J Am Chem Soc (2022) 144, 21035-21045. PubMed  Europe PubMed DOI  PMC  EPMC  K  I
  80. Novinec,M., Bembic,P., Jankovic,M., Kisilak,M., Kljun,J. and Turel,I.
    Kinetic Characterization of Cerium and Gallium Ions as Inhibitors of Cysteine Cathepsins L, K, and S
    Int J Mol Sci (2022) 23 PubMed  Europe PubMed DOI  PMC  EPMC
  81. Wang,S., Luke,C.J., Pak,S.C., Shi,V., Chen,L., Moore,J., Andress,A.P., Jayachandran,K., Zhang,J., Huang,Y., Platik,M., Apicelli,A.A., Schwarz,J.K., Grigsby,P.W., Silverman,G.A. and Markovina,S.
    SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation
    Commun Biol (2022) 5, 46-46. PubMed  Europe PubMed DOI  PMC  EPMC
  82. Wang,X., Liu,D., Liu,F., Xiao,L., Ni,H., Qi,X., Xing,K., Cai,D., Sheng,X. and Guo,Y.
    Cathepsin L involved in the freezing resistance of murine normal hatching embryos and dormant embryos
    Reprod Biol (2022) 22, 100612-100612. PubMed  Europe PubMed DOI
  83. Yang,W.L., Li,Q., Sun,J., Huat Tan,S., Tang,Y.H., Zhao,M.M., Li,Y.Y., Cao,X., Zhao,J.C. and Yang,J.K.
    Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy
    Comput Struct Biotechnol J (2022) 20, 2442-2454. PubMed  Europe PubMed DOI  PMC  EPMC  I
  84. Yoon,M.C., Ames,J., Mosier,C., Jiang,Z., Podvin,S., O'Donoghue,A.J. and Hook,V.
    Distinct Dibasic Cleavage Specificities of Neuropeptide-Producing Cathepsin L and Cathepsin V Cysteine Proteases Compared to PC1/3 and PC2 Serine Proteases
    ACS Chem Neurosci (2022) 13, 245-256. PubMed  Europe PubMed DOI
  85. Yu,F., Pan,T., Huang,F., Ying,R., Liu,J., Fan,H., Zhang,J., Liu,W., Lin,Y., Yuan,Y., Yang,T., Li,R., Zhang,X., Lv,X., Chen,Q., Liang,A., Zou,F., Liu,B., Hu,F., Tang,X., Li,L., Deng,K., He,X., Zhang,H., Zhang,Y. and Ma,X.
    Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L
    Front Microbiol (2022) 13, 884034-884034. PubMed  Europe PubMed DOI  PMC  EPMC  I
  86. Zhao,M.M., Zhu,Y., Zhang,L., Zhong,G., Tai,L., Liu,S., Yin,G., Lu,J., He,Q., Li,M.J., Zhao,R.X., Wang,H., Huang,W., Fan,C., Shuai,L., Wen,Z., Wang,C., He,X., Chen,Q., Liu,B., Xiong,X., Bu,Z., Wang,Y., Sun,F. and Yang,J.K.
    Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies
    Cell Discov (2022) 8, 53-53. PubMed  Europe PubMed DOI  PMC  EPMC
  87. 2021
  88. Almasi,F. and Mohammadipanah,F.
    Hypothetical targets and plausible drugs of coronavirus infection caused by SARS-CoV-2
    Transbound Emerg Dis (2021) 68, 318-332. PubMed  Europe PubMed DOI  PMC  EPMC
  89. Berdowska,I. and Matusiewicz,M.
    Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract
    World J Gastroenterol (2021) 27, 6590-6600. PubMed  Europe PubMed DOI  PMC  EPMC
  90. Bollavaram,K., Leeman,T.H., Lee,M.W., Kulkarni,A., Upshaw,S.G., Yang,J., Song,H. and Platt,M.O.
    Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V
    Protein Sci (2021) PubMed  Europe PubMed DOI
  91. Breidenbach,J., Lemke,C., Pillaiyar,T., Schakel,L., Al Hamwi,G., Diett,M., Gedschold,R., Geiger,N., Lopez,V., Mirza,S., Namasivayam,V., Schiedel,A.C., Sylvester,K., Thimm,D., Vielmuth,C., Phuong Vu,L., Zyulina,M., Bodem,J., Gutschow,M. and Muller,C.E.
    Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
    Angew Chem Int Ed Engl (2021) PubMed  Europe PubMed DOI  I
  92. Caval,T., Hecht,E.S., Tang,W., Uy-Gomez,M., Nichols,A., Kil,Y.J., Sandoval,W., Bern,M. and Heck,A.J.R.
    The lysosomal endopeptidases Cathepsin D and L are selective and effective proteases for the middle-down characterization of antibodies
    FEBS J (2021) PubMed  Europe PubMed DOI
  93. Choudhury,D. and Biswas,S.
    Structure-guided protein engineering of human cathepsin L for efficient collagenolytic activity
    Protein Eng Des Sel (2021) 34 PubMed  Europe PubMed DOI
  94. Dominguez-Hernandez,E. and Ertbjerg,P.
    Effect of LTLT heat treatment on cathepsin B and L activities and denaturation of myofibrillar proteins of pork
    Meat Sci (2021) 175, 108454-108454. PubMed  Europe PubMed DOI
  95. Eckl,K.M., Gruber,R., Brennan,L., Marriott,A., Plank,R., Moosbrugger-Martinz,V., Blunder,S., Schossig,A., Altmuller,J., Thiele,H., Nurnberg,P., Zschocke,J., Hennies,H.C. and Schmuth,M.
    Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Dysregulating Cathepsins L and V
    Front Genet (2021) 12, 689940-689940. PubMed  Europe PubMed DOI  PMC  EPMC
  96. Hu,Y., Ma,C., Szeto,T., Hurst,B., Tarbet,B. and Wang,J.
    Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
    ACS Infect Dis (2021) 7, 586-597. PubMed  Europe PubMed DOI  PMC  EPMC  I
  97. Huang,M., Chen,S.P., Dai,Y.Y., Yang,Y., Jiang,W., Wang,F., Zhang,J.X. and Zhu,Q.X.
    [Cathepsin L mediates glomerular endothelial cell injury by cleavaging complement C3 in trichloroethylene-sensitized mice]
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2021) 39, 5-11. PubMed  Europe PubMed DOI
  98. IstIflI,E.S., SihoGlu Tepe,A., Netz,P.A., SarikUrkcU,C., Kilic,I.H. and Tepe,B.
    Determination of the interaction between the receptor binding domain of 2019-nCoV spike protein, TMPRSS2, cathepsin B and cathepsin L, and glycosidic and aglycon forms of some flavonols
    Turk J Biol (2021) 45, 484-502. PubMed  Europe PubMed DOI  PMC  EPMC
  99. Jackson,C.B., Farzan,M., Chen,B. and Choe,H.
    Mechanisms of SARS-CoV-2 entry into cells
    Nat Rev Mol Cell Biol (2021) PubMed  Europe PubMed DOI  PMC  EPMC  V
  100. Kim,J.Y., Lee,E.J., Ahn,Y., Park,S., Bae,Y.J., Kim,T.G. and Oh,S.H.
    Cathepsin L, a Target of Hypoxia-Inducible Factor-1-alpha, Is Involved in Melanosome Degradation in Melanocytes
    Int J Mol Sci (2021) 22 PubMed  Europe PubMed DOI  PMC  EPMC
  101. Li,Y., Ai,X., Zou,C., Liu,Y., Ma,L., Men,J., Liu,D., Sheng,L., Ruan,X., Liu,H., Li,W., Ma,E. and Yuan,L.
    Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells
    Bioorg Chem (2021) 115, 105256-105256. PubMed  Europe PubMed DOI  I
  102. Mellott,D.M., Tseng,C.T., Drelich,A., Fajtova,P., Chenna,B.C., Kostomiris,D.H., Hsu,J., Zhu,J., Taylor,Z.W., Kocurek,K.I., Tat,V., Katzfuss,A., Li,L., Giardini,M.A., Skinner,D., Hirata,K., Yoon,M.C., Beck,S., Carlin,A.F., Clark,A.E., Beretta,L., Maneval,D., Hook,V., Frueh,F., Hurst,B.L., Wang,H., Raushel,F.M., O'Donoghue,A.J., de Siqueira-Neto,J.L., Meek,T.D. and McKerrow,J.H.
    A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells
    ACS Chem Biol (2021) 16, 642-650. PubMed  Europe PubMed DOI  PMC  EPMC  I
  103. Munikishore,R., Wang,L.L., Zhang,S., Zhao,Q.S. and Zuo,Z.
    An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94
    Bioorg Chem (2021) 116, 105317-105317. PubMed  Europe PubMed DOI  I
  104. Nagahama,M., Kobayashi,K. and Takehara,M.
    Cathepsin Release from Lysosomes Promotes Endocytosis of Clostridium perfringens Iota-Toxin
    Toxins (Basel) (2021) 13 PubMed  Europe PubMed DOI  PMC  EPMC
  105. Pathak,M., Vani,V. and Seshagiri,P.B.
    Expression and function of interleukin-1beta is required for hamster blastocyst hatching: Involvement of hatching-associated cathepsin proteases
    Mol Reprod Dev (2021) 88, 274-286. PubMed  Europe PubMed DOI
  106. Phan,H.A.T., Giannakoulias,S.G., Barrett,T.M., Liu,C. and Petersson,E.J.
    Rational design of thioamide peptides as selective inhibitors of cysteine protease cathepsin L
    Chem Sci (2021) 12, 10825-10835. PubMed  Europe PubMed DOI  PMC  EPMC  I
  107. Reed,B., Crawford,F., Hill,R.C., Jin,N., White,J., Krovi,S.H., Marrack,P., Hansen,K. and Kappler,J.W.
    Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation
    J Exp Med (2021) 218 PubMed  Europe PubMed DOI
  108. Sankpal,N.V., Brown,T.C., Fleming,T.P., Herndon,J.M., Amaravati,A.A., Loynd,A.N. and Gillanders,W.E.
    Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion
    BMC Cancer (2021) 21, 541-541. PubMed  Europe PubMed DOI  PMC  EPMC
  109. Schleyer,K.A., Fetrow,B., Fatland,P.Z., Liu,J., Chaaban,M., Ma,B. and Cui,L.
    Intrinsically quenched fluorogenic probe provides selective and rapid detection of cathepsin L activity
    ChemMedChem (2021) 16, 1082-1087. PubMed  Europe PubMed DOI
  110. Seyedpour,S., Khodaei,B., Loghman,A.H., Seyedpour,N., Kisomi,M.F., Balibegloo,M., Nezamabadi,S.S., Gholami,B., Saghazadeh,A. and Rezaei,N.
    Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
    J Cell Physiol (2021) 236, 2364-2392. PubMed  Europe PubMed DOI
  111. Shibamura-Fujiogi,M., Yuki,K. and Hou,L.
    Cathepsin L regulates pathogenicCD4 T cells in experimental autoimmune encephalomyelitis
    Int Immunopharmacol (2021) 93, 107425-107425. PubMed  Europe PubMed DOI
  112. Steuten,K., Kim,H., Widen,J.C., Babin,B.M., Onguka,O., Lovell,S., Bolgi,O., Cerikan,B., Neufeldt,C.J., Cortese,M., Muir,R.K., Bennett,J.M., Geiss-Friedlander,R., Peters,C., Bartenschlager,R. and Bogyo,M.
    Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
    ACS Infect Dis (2021) PubMed  Europe PubMed DOI  PMC  EPMC
  113. Tsegaye,S., Mehdi,M., Labisso,W.L. and Melka,D.S.
    Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients
    Breast Cancer (Dove Med Press) (2021) 13, 271-283. PubMed  Europe PubMed DOI  PMC  EPMC  L
  114. Valois,M.V., de Oliveira,C., Lapa,A.J., Souccar,C. and Oliva,M.L.V.
    Bauhinia Protease Inhibitors Attenuate Gastric Ulcer by Blocking Neutrophil Enzymes
    Planta Med (2021) 87, 169-176. PubMed  Europe PubMed DOI
  115. Yang,J., Chen,T. and Zhou,Y.
    Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes
    Hereditas (2021) 158, 4-4. PubMed  Europe PubMed DOI  PMC  EPMC
  116. Yu,C., Wan,Y., Xu,W., Jin,X., Zhang,S., Xin,M., Jiang,H. and Cheng,X.
    Increased Circulating Cathepsin L in Patients with Coronary Artery Disease
    Int Heart J (2021) 62, 9-15. PubMed  Europe PubMed DOI
  117. Zhao,M.M., Yang,W.L., Yang,F.Y., Zhang,L., Huang,W.J., Hou,W., Fan,C.F., Jin,R.H., Feng,Y.M., Wang,Y.C. and Yang,J.K.
    Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development
    Signal Transduct Target Ther (2021) 6, 134-134. PubMed  Europe PubMed DOI  PMC  EPMC  K
  118. 2020
  119. Abhinand,C.S., Nair,A.S., Krishnamurthy,A., Oommen,O.V. and Sudhakaran,P.R.
    Potential protease inhibitors and their combinations to block SARS-CoV-2
    J Biomol Struct Dyn (2020) , 1-15. PubMed  Europe PubMed DOI  PMC  EPMC  I
  120. Arafet,K., Gonzalez,F.V. and Moliner,V.
    Quantum mechanics/molecular mechanics studies of the mechanism of cysteine proteases inhibition by dipeptidyl nitroalkenes
    Chemistry (2020) 26, 2002-2012. PubMed  Europe PubMed DOI  I
  121. Ashhurst,A.S., Tang,A.H., Fajtova,P., Yoon,M., Aggarwal,A., Stoye,A., Larance,M., Beretta,L., Drelich,A., Skinner,D., Li,L., Meek,T.D., McKerrow,J.H., Hook,V., Tseng,C.K., Turville,S., Gerwick,W.H., O'Donoghue,A.J. and Payne,R.J.
    Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L
    bioRxiv (2020) PubMed  Europe PubMed DOI  PMC  EPMC  I
  122. Barnett,B.P., Wahlin,K., Krawczyk,M., Spencer,D., Welsbie,D., Afshari,N. and Chao,D.
    Potential of Ocular Transmission of SARS-CoV-2: A Review
    Vision (Basel) (2020) 4 PubMed  Europe PubMed DOI  V
  123. Blaess,M., Kaiser,L., Sauer,M., Csuk,R. and Deigner,H.P.
    COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks
    Int J Mol Sci (2020) 21 PubMed  Europe PubMed DOI  PMC  EPMC
  124. Braz,H.L.B., Silveira,J.A.M., Marinho,A.D., de Moraes,M.E.A., Moraes Filho,M.O., Monteiro,H.S.A. and Jorge,R.J.B.
    In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
    Int J Antimicrob Agents (2020) , 106119-106119. PubMed  Europe PubMed DOI  PMC  EPMC
  125. Brings,S., Fleming,T., Herzig,S., Nawroth,P.P. and Kopf,S.
    Urinary cathepsin L is predictive of changes in albuminuria and correlates with glucosepane in patients with type 2 diabetes in a closed-cohort study
    J Diabetes Complications (2020) , 107648-107648. PubMed  Europe PubMed DOI
  126. Chen,J., Zhang,L., Yang,N., Cao,M., Tian,M., Fu,Q., Su,B. and Li,C.
    Characterization of the immune roles of cathepsin L in turbot (Scophthalmus maximus L.) mucosal immunity
    Fish Shellfish Immunol (2020) 97, 322-335. PubMed  Europe PubMed DOI
  127. Cianni,L., Rocho,F.D.R., Rosini,F., Bonatto,V., Ribeiro,J.F.R., Lameira,J., Leitao,A., Shamim,A. and Montanari,C.A.
    Optimization strategy of single-digit nanomolar cross-class inhibitors of mammalian and protozoa cysteine proteases
    Bioorg Chem (2020) 101, 104039-104039. PubMed  Europe PubMed DOI  I
  128. Dana,D. and Pathak,S.K.
    A review of small molecule inhibitors and functional probes of human cathepsin L
    Molecules (2020) 25 PubMed  Europe PubMed DOI  V  I
  129. Eapen,M.S., Lu,W., Hackett,T.L., Singhera,G.K., Thompson,I.E., McAlinden,K.D., Hardikar,A., Weber,H.C., Haug,G., Wark,P.A.B., Chia,C. and Sohal,S.S.
    Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections
    Am J Physiol Lung Cell Mol Physiol (2020) PubMed  Europe PubMed DOI
  130. Filippova,I.Y., Dvoryakova,E.A., Sokolenko,N.I., Simonyan,T.R., Tereshchenkova,V.F., Zhiganov,N.I., Dunaevsky,Y.E., Belozersky,M.A., Oppert,B. and Elpidina,E.N.
    New Glutamine-Containing Substrates for the Assay of Cysteine Peptidases From the C1 Papain Family
    Front Mol Biosci (2020) 7, 578758-578758. PubMed  Europe PubMed DOI  PMC  EPMC
  131. Fonseca Lameiro,R.D., Shamim,A., Rosini,F., Cendron,R., Jatai Batista,P.H. and Montanari,C.A.
    Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds
    Future Med Chem (2020) PubMed  Europe PubMed DOI
  132. Gomes,C.P., Fernandes,D.E., Casimiro,F., da Mata,G.F., Passos,M.T., Varela,P., Mastroianni-Kirsztajn,G. and Pesquero,J.B.
    Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics
    Front Cell Infect Microbiol (2020) 10, 589505-589505. PubMed  Europe PubMed DOI  PMC  EPMC
  133. Jaimes,J., Millet,J. and Whittaker,G.
    Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site
    SSRN (2020) , 3581359-3581359. PubMed  Europe PubMed DOI  PMC  EPMC
  134. Kerslake,R., Hall,M., Randeva,H.S., Spandidos,D.A., Chatha,K., Kyrou,I. and Karteris,E.
    Coexpression of peripheral olfactory receptors with SARSCoV2 infection mediators: Potential implications beyond loss of smell as a COVID19 symptom
    Int J Mol Med (2020) 46, 949-956. PubMed  Europe PubMed DOI  PMC  EPMC
  135. Kodama,R.T., Kuniyoshi,A.K., da Silva,C.C.F., Cajado-Carvalho,D., Duzzi,B., Mariano,D.C., Pimenta,D.C., Borges,R., da Silva,W.D. and Portaro,F.C.V.
    A Kunitz-type peptide from Dendroaspis polylepis venom as a simultaneous inhibitor of serine and cysteine proteases
    J Venom Anim Toxins Incl Trop Dis (2020) 26, e20200037-e20200037. PubMed  Europe PubMed DOI  PMC  EPMC
  136. Li,H., Xie,L., Chen,L., Zhang,L., Han,Y., Yan,Z. and Guo,X.
    Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer
    Aging (Albany NY) (2020) 12, 22370-22389. PubMed  Europe PubMed DOI
  137. Liu,H., Gai,S., Wang,X., Zeng,J., Sun,C., Zhao,Y. and Zheng,Z.
    Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart
    Cardiovasc Res (2020) 116, 1733-1741. PubMed  Europe PubMed DOI
  138. Madadlou,A.
    Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2
    Eur J Pharmacol (2020) 885, 173499-173499. PubMed  Europe PubMed DOI  PMC  EPMC
  139. Mellott,D., Tseng,C.T., Drelich,A., Fajtova,P., Chenna,B.C., Kostomiris,D., Hsu,J.C., Zhu,J., Taylor,Z., Tat,V., Katzfuss,A., Li,L., Giardini,M.A., Skinner,D., Hirata,K., Beck,S., Carlin,A.F., Clark,A.E., Berreta,L., Maneval,D., Frueh,F., Hurst,B.L., Wang,H., Kocurek,K.I., Raushel,F.M., O'Donoghue,A., Siqueira-Neto,J.L., Meek,T.D. and McKerrow,J.H.
    A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells
    bioRxiv (2020) PubMed  Europe PubMed DOI  PMC  EPMC  I
  140. Mishra,C.B., Pandey,P., Sharma,R.D., Malik,M.Z., Mongre,R.K., Lynn,A.M., Prasad,R., Jeon,R. and Prakash,A.
    Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach
    Brief Bioinform (2020) PubMed  Europe PubMed DOI  PMC  EPMC
  141. Mishra,M., Singh,V., Tellis,M.B., Joshi,R.S. and Singh,S.
    Repurposing the McoTI-II Rigid Molecular Scaffold in to Inhibitor of 'Papain Superfamily' Cysteine Proteases
    Pharmaceuticals (Basel) (2020) 14 PubMed  Europe PubMed DOI  PMC  EPMC
  142. Niu,R., Wang,J., Geng,C., Li,Y., Dong,L., Liu,L., Chang,Y., Shen,J., Nie,Z., Zhang,Y. and Hu,B.
    Tandem mass tag-based proteomic analysis reveals cathepsin-mediated anti-autophagic and pro-apoptotic effects under proliferative diabetic retinopathy
    Aging (Albany NY) (2020) 12 PubMed  Europe PubMed DOI
  143. Padmanabhan,P., Desikan,R. and Dixit,N.M.
    Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
    PLoS Comput Biol (2020) 16, e1008461-e1008461. PubMed  Europe PubMed DOI
  144. Parigiani,M.A., Ketscher,A., Timme,S., Bronsert,P., Schlimpert,M., Kammerer,B., Jacquel,A., Chaintreuil,P. and Reinheckel,T.
    Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression
    Cancers (Basel) (2020) 12 PubMed  Europe PubMed DOI  K
  145. Pritsch,I.C., Tikhonova,I.G., Jewhurst,H.L., Drysdale,O., Cwiklinski,K., Molento,M.B., Dalton,J.P. and Verissimo,C.M.
    Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition
    BMC Mol Cell Biol (2020) 21, 90-90. PubMed  Europe PubMed DOI  PMC  EPMC
  146. Prunk,M., Perisic Nanut,M., Jakos,T., Sabotic,J., Svajger,U. and Kos,J.
    Extracellular Cystatin F Is Internalised by Cytotoxic T Lymphocytes and Decreases Their Cytotoxicity
    Cancers (Basel) (2020) 12 PubMed  Europe PubMed DOI  PMC  EPMC
  147. Ribeiro,J.F.R., Cianni,L., Li,C., Warwick,T.G., De Vita,D., Rosini,F., Dos Reis Rocho,F., Martins,F.C.P., Kenny,P.W., Lameira,J., Leitao,A., Emsley,J. and Montanari,C.A.
    Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor
    Bioorg Med Chem (2020) 28, 115743-115743. PubMed  Europe PubMed DOI  I
  148. Sacco,M.D., Ma,C., Lagarias,P., Gao,A., Townsend,J.A., Meng,X., Dube,P., Zhang,X., Hu,Y., Kitamura,N., Hurst,B., Tarbet,B., Marty,M.T., Kolocouris,A., Xiang,Y., Chen,Y. and Wang,J.
    Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M(pro) and cathepsin L
    bioRxiv (2020) PubMed  Europe PubMed DOI  PMC  EPMC  I
  149. Sacco,M.D., Ma,C., Lagarias,P., Gao,A., Townsend,J.A., Meng,X., Dube,P., Zhang,X., Hu,Y., Kitamura,N., Hurst,B., Tarbet,B., Marty,M.T., Kolocouris,A., Xiang,Y., Chen,Y. and Wang,J.
    Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M(pro) and cathepsin L
    Sci Adv (2020) PubMed  Europe PubMed DOI  I
  150. Seth,S., Batra,J. and Srinivasan,S.
    COVID-19: Targeting Proteases in Viral Invasion and Host Immune Response
    Front Mol Biosci (2020) 7, 215-215. PubMed  Europe PubMed DOI  PMC  EPMC  V
  151. Shi,X. and Zhang,Y.
    A humanized antibody inhibitor for cathepsin L
    Protein Sci (2020) 29, 1924-1930. PubMed  Europe PubMed DOI
  152. Smith,D., Cwiklinski,K., Jewhurst,H., Tikhonova,I.G. and Dalton,J.P.
    An atypical and functionally diverse family of Kunitz-type cysteine/serine proteinase inhibitors secreted by the helminth parasite Fasciola hepatica
    Sci Rep (2020) 10, 20657-20657. PubMed  Europe PubMed DOI  PMC  EPMC
  153. Toman,N.P., Kamenik,A.S., Santos,L.H., Hofer,F., Liedl,K.R. and Ferreira,R.S.
    Profiling selectivity of chagasin mutants towards cysteine proteases cruzain or cathepsin L through molecular dynamics simulations
    J Biomol Struct Dyn (2020) , 1-13. PubMed  Europe PubMed DOI
  154. Ulcakar,L. and Novinec,M.
    Inhibition of Human Cathepsins B and L by Caffeic Acid and Its Derivatives
    Biomolecules (2020) 11 PubMed  Europe PubMed DOI  PMC  EPMC
  155. Vargas-Alarcon,G., Posadas-Sanchez,R. and Ramirez-Bello,J.
    Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies
    Life Sci (2020) 260, 118313-118313. PubMed  Europe PubMed DOI  PMC  EPMC
  156. Vivek-Ananth,R.P., Rana,A., Rajan,N., Biswal,H.S. and Samal,A.
    In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection
    Molecules (2020) 25 PubMed  Europe PubMed DOI
  157. Wang,Z., Xiang,Z., Zhu,T., Chen,J., Zhong,M.Z., Huang,J., Wang,K.S., Li,L., Sun,L.Q. and Zhou,W.B.
    Cathepsin L interacts with CDK2-AP1 as a potential predictor of prognosis in patients with breast cancer
    Oncol Lett (2020) 19, 167-176. PubMed  Europe PubMed DOI  PMC  EPMC
  158. 2019
  159. Boudreau,P.D., Miller,B.W., McCall,L.I., Almaliti,J., Reher,R., Hirata,K., Le,T., Siqueira-Neto,J.L., Hook,V. and Gerwick,W.H.
    Design of gallinamide A analogs as potent inhibitors of the cysteine proteases human cathepsin L and Trypanosoma cruzi cruzain
    J Med Chem (2019) 62, 9026-9044. PubMed  Europe PubMed DOI  I
  160. Dana,D., Garcia,J., Bhuiyan,A.I., Rathod,P., Joo,L., Novoa,D.A., Paroly,S., Fath,K.R., Chang,E.J. and Pathak,S.K.
    Cell penetrable, clickable and tagless activity-based probe of human cathepsin L
    Bioorg Chem (2019) 85, 505-514. PubMed  Europe PubMed DOI  L  I
  161. Luo,H., Tie,L., Cao,M., Hunter,A.K., Pabst,T.M., Du,J., Field,R., Li,Y. and Wang,W.K.
    Cathepsin L causes proteolytic cleavage of Chinese hamste-ovary-cell expressed proteins during processing and storage: identification characterization and mitigation
    Biotechnol Prog (2019) 35, e2732-e2732. PubMed  Europe PubMed DOI
  162. Ma,K.X., Song,G.G., Wu,M., Zhang,H.C., Chen,G.W. and Liu,D.Z.
    Identification of a potential tissue-specific biomarker cathepsin L-like gene from the planarian Dugesia japonica: molecular cloning, characterization, and expression in response to heavy metal exposure
    Ecotoxicol Environ Saf (2019) 180, 73-79. PubMed  Europe PubMed DOI
  163. Papanastasiou,M., Mullahoo,J., DeRuff,K.C., Bajrami,B., Karageorgos,I., Johnston,S.E., Peckner,R., Myers,S.A., Carr,S.A. and Jaffe,J.D.
    Chasing tails: cathepsin-L improves structural analysis of histones by HX-MS
    Mol Cell Proteomics (2019) 18, 2089-2098. PubMed  Europe PubMed DOI
  164. Parks,A.N., Nahata,J., Edouard,N.E., Temenoff,J.S. and Platt,M.O.
    Sequential, but not concurrent, incubation of cathepsin K and L with type I collagen results in extended proteolysis
    Sci Rep (2019) 9, 5399-5399. PubMed  Europe PubMed DOI  PMC  EPMC
  165. Pranjol,M.Z.I., Gutowski,N.J., Hannemann,M. and Whatmore,J.L.
    Cathepsin L induces proangiogenic changes in human omental microvascular endothelial cells via activation of the ERK1/2 pathway
    Curr Cancer Drug Targets (2019) 19, 231-242. PubMed  Europe PubMed DOI
  166. Shockey,W.A., Kieslich,C.A., Wilder,C.L., Watson,V. and Platt,M.O.
    Dynamic model of protease state and inhibitor trafficking to predict protease activity in breast cancer cells
    Cell Mol Bioeng (2019) 12, 275-288. PubMed  Europe PubMed DOI  PMC  EPMC  I
  167. Tokarzewicz,A., Romanowicz,L., Sankiewicz,A., Hermanowicz,A., Sobolewski,K. and Gorodkiewicz,E.
    A new analytical method for determination of cathepsin L based on the surface plasmon resonance imaging biosensor
    Int J Mol Sci (2019) 20 PubMed  Europe PubMed DOI  A
  168. Weiss-Sadan,T., Itzhak,G., Kaschani,F., Yu,Z., Mahameed,M., Anaki,A., Ben-Nun,Y., Merquiol,E., Tirosh,B., Kessler,B., Kaiser,M. and Blum,G.
    Cathepsin L regulates metabolic networks controlling rapid cell growth and proliferation
    Mol Cell Proteomics (2019) 18, 1330-1344. PubMed  Europe PubMed DOI  I
  169. Xue,Q., Wu,X.Q., Zhang,W.J., Deng,L.N. and Wu,M.M.
    Cathepsin L-like cysteine proteinase genes are associated with the development and pathogenicity of pine wood nematode, Bursaphelenchus xylophilus
    Int J Mol Sci (2019) 20 PubMed  Europe PubMed DOI
  170. Yuan,L., Liu,J., He,W., Bao,Y., Sheng,L., Zou,C., Hu,B., Ge,W., Liu,Y., Wang,J., Lin,B., Li,Y. and Ma,E.
    Discovery of a novel cathepsin inhibitor with dual autophagy-inducing and metastasis-inhibiting effects on breast cancer cells
    Bioorg Chem (2019) 84, 239-253. PubMed  Europe PubMed DOI  I
  171. Yuan,L., Zou,C., Ge,W., Liu,Y., Hu,B., Wang,J., Lin,B., Li,Y. and Ma,E.
    A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis
    Bioorg Chem (2019) , 103417-103417. PubMed  Europe PubMed DOI  I
  172. 2018
  173. Aich,P. and Biswas,S.
    Highly conserved Arg residue of ERFNIN motif of pro-domain is important for pH-induced zymogen activation process in cysteine cathepsins K and L
    Cell Biochem Biophys (2018) 76, 219-229. PubMed  Europe PubMed DOI
  174. Douglas,S.A., Lamothe,S.E., Singleton,T.S., Averett,R.D. and Platt,M.O.
    Human cathepsins K, L, and S: related proteases, but unique fibrinolytic activity
    Biochim Biophys Acta (2018) 1862, 1925-1932. PubMed  Europe PubMed DOI
  175. Freeley,S., Cardone,J., Gunther,S.C., West,E.E., Reinheckel,T., Watts,C., Kemper,C. and Kolev,M.V.
    Asparaginyl endopeptidase (legumain) supports human Th1 induction via cathepsin L-mediated intracellular C3 activation
    Front Immunol (2018) 9, 2449-2449. PubMed  Europe PubMed DOI  PMC  EPMC
  176. Huisman,M., Kodanko,J.P., Arora,K., Herroon,M., Alnaed,M., Endicott,J., Podgorski,I. and Kodanko,J.J.
    Affinity-enhanced luminescent Re(I)- and Ru(II)-based inhibitors of the cysteine protease cathepsin L
    Inorg Chem (2018) 57, 7881-7891. PubMed  Europe PubMed DOI  I
  177. Peyer,S.M., Kremer,N. and McFall-Ngai,M.J.
    Involvement of a host cathepsin L in symbiont-induced cell death
    Microbiologyopen (2018) , e00632-e00632. PubMed  Europe PubMed DOI
  178. Podvin,S., Wojnicz,A. and Hook,V.
    Human brain gene expression profiles of the cathepsin V and cathepsin L cysteine proteases, with the PC1/3 and PC2 serine proteases, involved in neuropeptide production
    Heliyon (2018) 4, e00673-e00673. PubMed  Europe PubMed DOI  PMC  EPMC
  179. Poreba,M., Rut,W., Vizovisek,M., Groborz,K., Kasperkiewicz,P., Finlay,D., Vuori,K., Turk,D., Turk,B., Salvesen,G.S. and Drag,M.
    Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes
    Chem Sci (2018) 9, 2113-2129. PubMed  Europe PubMed DOI  PMC  EPMC  L
  180. Streubel,M.K., Bischof,J., Weiss,R., Duschl,J., Liedl,W., Wimmer,H., Breitenbach,M., Weber,M., Geltinger,F., Richter,K. and Rinnerthaler,M.
    Behead and live long or the tale of cathepsin L
    Yeast (2018) 35, 237-249. PubMed  Europe PubMed DOI
  181. 2017
  182. Dai,L.S., Chu,S.H., Yu,X.M. and Li,Y.Y.
    A role of cathepsin L gene in innate immune response of crayfish (Procambarus clarkii)
    Fish Shellfish Immunol (2017) 71, 246-254. PubMed  Europe PubMed DOI
  183. Dos Santos,D.A., Deobald,A.M., Cornelio,V.E., Avila,R.M.D., Cornea,R.C., Bernasconi,G.C.R., Paixao,M.W., Vieira,P.C. and Correa,A.G.
    Asymmetric synthesis and evaluation of epoxy-alpha-acyloxycarboxamides as selective inhibitors of cathepsin L
    Bioorg Med Chem (2017) 25, 4620-4627. PubMed  Europe PubMed DOI  I
  184. Giroud,M., Ivkovic,J., Martignoni,M., Fleuti,M., Trapp,N., Haap,W., Kuglstatter,A., Benz,J., Kuhn,B., Schirmeister,T. and Diederich,F.
    Inhibition of the cysteine protease human cathepsin L by triazine nitriles: amide???heteroarene pi-stacking interactions and chalcogen bonding in the S3 pocket
    ChemMedChem (2017) 12, 257-270. PubMed  Europe PubMed DOI  I
  185. Hashimoto,Y.
    Gelatin zymography using leupeptin for the detection of various cathepsin L forms
    Methods Mol Biol (2017) 1594, 243-254. PubMed  Europe PubMed DOI  L  I
  186. Kikuta,S., Murai,Y. and Tanaka,E.
    Activation of cathepsin L contributes to the irreversible depolarization induced by oxygen and glucose deprivation in rat hippocampal CA1 neurons
    Neurosci Lett (2017) 636, 120-126. PubMed  Europe PubMed DOI  I
  187. Kuhn,B., Tichy,M., Wang,L., Robinson,S., Martin,R.E., Kuglstatter,A., Benz,J., Giroud,M., Schirmeister,T., Abel,R., Diederich,F. and Hert,J.
    Prospective evaluation of free energy calculations for the prioritization of cathepsin L inhibitors
    J Med Chem (2017) 60, 2485-2497. PubMed  Europe PubMed DOI  I
  188. Lee,C.W., Stankowski,J.N., Chew,J., Cook,C.N., Lam,Y.W., Almeida,S., Carlomagno,Y., Lau,K.F., Prudencio,M., Gao,F.B., Bogyo,M., Dickson,D.W. and Petrucelli,L.
    The lysosomal protein cathepsin L is a progranulin protease
    Mol Neurodegener (2017) 12, 55-55. PubMed  Europe PubMed DOI  PMC  EPMC
  189. Li,Y.Y., Fang,J. and Ao,G.Z.
    Cathepsin B and L inhibitors: a patent review (2010 - present)
    Expert Opin Ther Pat (2017) 27, 643-656. PubMed  Europe PubMed DOI  V  I
  190. Liang,F.R., Hong,Y.H., Ye,C.C., Deng,H., Yuan,J.P., Hao,Y.F. and Wang,J.H.
    Molecular characterization and gene expression of cathepsin L in Nile tilapia (Oreochromis niloticus)
    Fish Shellfish Immunol (2017) 67, 280-292. PubMed  Europe PubMed DOI
  191. McGlinchey,R.P., Dominah,G.A. and Lee,J.C.
    Taking a bite out of amyloid: mechanistic insights into alpha-synuclein degradation by cathepsin L
    Biochemistry (2017) 56, 3881-3884. PubMed  Europe PubMed DOI
  192. Parker,E.N., Odutola,S.O., Wang,Y., Strecker,T.E., Mukherjee,R., Shi,Z., Chaplin,D.J., Trawick,M.L. and Pinney,K.G.
    Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L
    Bioorg Med Chem Lett (2017) 27, 1304-1310. PubMed  Europe PubMed DOI  I
  193. Qi,Z., Huang,B., Zhang,Q., Wang,Z., Wang,P. and Gao,Q.
    Molecular characterization, expression and evolutionary analysis of 3 cathepsin genes (CTSH, CTSL and CTSS) from Chinese giant salamander (Andrias davidianus)
    Gene Rep (2017) 7, 25-31. DOI
  194. Qiao,Y., Wang,J., Mao,Y., Liu,M., Song,X., Su,Y., Wang,C. and Zheng,Z.
    Identification and molecular characterization of cathepsin L gene and its expression analysis during early ontogenetic development of kuruma shrimp Marsupenaeus japonicus
    Acta Oceanol Sin (2017) 36, 52-60. DOI
  195. Xu,S., Zhang,H., Yang,X., Qian,Y. and Xiao,Q.
    Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-kappaB pathways
    Neurobiol Aging (2017) 62, 159-167. PubMed  Europe PubMed DOI  T
  196. 2016
  197. Burton,L.J., Dougan,J., Jones,J., Smith,B.N., Randle,D., Henderson,V. and Odero-Marah,V.A.
    Targeting the nuclear cathepsin L- CCAAT-displacement protein/cut homeobox transcription factor-epithelial mesenchymal transition pathway in prostate and breast cancer cells with Z-FY-CHO inhibitor
    Mol Cell Biol (2016) 37, e00297-16.-e00297-16. PubMed  Europe PubMed DOI  I
  198. Castro-Gomes,T., Corrotte,M., Tam,C. and Andrews,N.W.
    Plasma membrane repair is regulated extracellularly by proteases released from lysosomes
    PLoS ONE (2016) 11, e0152583-e0152583. PubMed  Europe PubMed DOI  PMC  EPMC
  199. Garsen,M., Rops,A.L., Dijkman,H., Willemsen,B., van Kuppevelt,T.H., Russel,F.G., Rabelink,T.J., Berden,J.H., Reinheckel,T. and van der Vlag,J.
    Cathepsin L is crucial for the development of early experimental diabetic nephropathy
    Kidney Int (2016) 90, 1012-1022. PubMed  Europe PubMed DOI  T
  200. Giroud,M., Harder,M., Kuhn,B., Haap,W., Trapp,N., Schweizer,W.B., Schirmeister,T. and Diederich,F.
    Fluorine scan of inhibitors of the cysteine protease human cathepsin L: dipolar and quadrupolar effects in the pi-stacking of fluorinated phenyl rings on peptide amide bonds
    ChemMedChem (2016) 11, 1042-1047. PubMed  Europe PubMed DOI  I
  201. Hofmann,N., Galetskiy,D., Rauch,D., Wittmann,T., Marquardt,A., Griese,M. and Zarbock,R.
    Analysis of the proteolytic processing of ABCA3: identification of cleavage site and involved proteases
    PLoS ONE (2016) 11, e0152594-e0152594. PubMed  Europe PubMed DOI  P
  202. Mori,J., Tanikawa,C., Funauchi,Y., Lo,P.H., Nakamura,Y. and Matsuda,K.
    Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity
    Cancer Sci (2016) 107, 298-306. PubMed  Europe PubMed DOI
  203. Ohrvik,H., Logeman,B., Turk,B., Reinheckel,T. and Thiele,D.J.
    Cathepsin protease controls copper and cisplatin accumulation via cleavage of the Ctr1 metal-binding ectodomain
    J Biol Chem (2016) 291, 13905-13916. PubMed  Europe PubMed DOI
  204. Raghav,N., Jangra,S., Kumar,A., Bhattacharyya,S., Wadhwa,D. and Sindhu,J.
    Cathepsin B, H and L inhibitors as cell proliferating agents: design, synthesis, computational and pharmacological studies of some novel 2-(2-naphthoyl)-6,6-dimethyl-3-aryl-2,3,6,7-tetrahydrobenzofuran-4(5H)-ones
    RSC Adv (2016) 6, 34588-34599. DOI  I
  205. Shirato,K., Kanou,K., Kawase,M. and Matsuyama,S.
    Clinical isolates of human coronavirus 229E bypass the endosome for cell entry
    J Virol (2016) 91, e01387-16-e01387-16. PubMed  Europe PubMed DOI
  206. Sosnowski,P. and Turk,D.
    Caught in the act: the crystal structure of cleaved cathepsin L bound to the active site of cathepsin L
    FEBS Lett (2016) 590, 1253-1261. PubMed  Europe PubMed DOI  S
  207. Sudhan,D.R., Pampo,C., Rice,L. and Siemann,D.W.
    Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model
    Int J Cancer (2016) 138, 2665-2677. PubMed  Europe PubMed DOI  I
  208. Sudhan,D.R., Rabaglino,M.B., Wood,C.E. and Siemann,D.W.
    Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94
    Clin Exp Metastasis (2016) 33, 461-473. PubMed  Europe PubMed DOI  I
  209. Tamhane,T., Lllukkumbura,R., Lu,S., Maelandsmo,G.M., Haugen,M.H. and Brix,K.
    Nuclear cathepsin L activity is required for cell cycle progression of colorectal carcinoma cells
    Biochimie (2016) 122, 208-218. PubMed  Europe PubMed DOI
  210. Ueki,N., Wang,W., Swenson,C., McNaughton,C., Sampson,N.S. and Hayman,M.J.
    Synthesis and preclinical evaluation of a highly improved anticancer prodrug activated by histone deacetylases and cathepsin L
    Theranostics (2016) 6, 808-816. PubMed  Europe PubMed DOI  PMC  EPMC  I
  211. Withana,N.P., Garland,M., Verdoes,M., Ofori,L.O., Segal,E. and Bogyo,M.
    Labeling of active proteases in fresh-frozen tissues by topical application of quenched activity-based probes
    Nat Protoc (2016) 11, 184-191. PubMed  Europe PubMed DOI  L
  212. Withana,N.P., Ma,X., McGuire,H.M., Verdoes,M., van der Linden,W.A., Ofori,L.O., Zhang,R., Li,H., Sanman,L.E., Wei,K., Yao,S., Wu,P., Li,F., Huang,H., Xu,Z., Wolters,P.J., Rosen,G.D., Collard,H.R., Zhu,Z., Cheng,Z. and Bogyo,M.
    Non-invasive imaging of idiopathic pulmonary fibrosis using cathepsin protease probes
    Sci Rep (2016) 6, 19755-19755. PubMed  Europe PubMed DOI  PMC  EPMC  L
  213. Yang,J., Liu,H., Zheng,G., Xiang,X., Lv,Z. and Wang,T.
    Cathepsin L of the sea cucumber Apostichopus japonicus-molecular characterization and transcriptional response to Vibrio splendidus infection
    Fish Shellfish Immunol (2016) 49, 387-395. PubMed  Europe PubMed DOI
  214. Zhang,H., Zhang,L., Wei,L., Gao,X., Tang,L., Gong,W., Min,N., Zhang,L. and Yuan,Y.
    Knockdown of cathepsin L sensitizes ovarian cancer cells to chemotherapy
    Oncol Lett (2016) 11, 4235-4239. PubMed  Europe PubMed DOI  K
  215. Zhou,N., Pan,T., Zhang,J., Li,Q., Zhang,X., Bai,C., Huang,F., Peng,T., Zhang,J., Liu,C., Tao,L. and Zhang,H.
    Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
    J Biol Chem (2016) 291, 9218-9232. PubMed  Europe PubMed DOI  I
  216. 2015
  217. Andrault,P.M., Samsonov,S.A., Weber,G., Coquet,L., Nazmi,K., Bolscher,J.G., Lalmanach,A.C., Jouenne,T., Bromme,D., Pisabarro,M.T., Lalmanach,G. and Lecaille,F.
    Antimicrobial peptide LL-37 is both a substrate of cathepsins S and K and a selective inhibitor of cathepsin L
    Biochemistry (2015) 54, 2785-2798. PubMed  Europe PubMed DOI
  218. Brindle,N.R., Joyce,J.A., Rostker,F., Lawlor,E.R., Swigart-Brown,L., Evan,G., Hanahan,D. and Shchors,K.
    Deficiency for the cysteine protease cathepsin L impairs myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer
    PLoS ONE (2015) 10, e0120348- PubMed  Europe PubMed DOI  PMC  EPMC  K
  219. Celis-Barros,C., Saavedra-Rivas,L., Salgado,J.C., Cassels,B.K. and Zapata-Torres,G.
    Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition
    J Comput Aided Mol Des (2015) 29, 37-46. PubMed  Europe PubMed DOI  I
  220. Corry,J., Johnson,S.M., Cornwell,J. and Peeples,M.E.
    Preventing cleavage of the respiratory syncytial virus attachment protein in Vero cells rescues the infectivity of progeny virus for primary human airway cultures
    J Virol (2015) 90, 1311-1320. PubMed  Europe PubMed DOI
  221. Gu,Y.H., Kanazawa,M., Hung,S.Y., Wang,X., Fukuda,S., Koziol,J.A. and del Zoppo,G.J.
    Cathepsin L acutely alters microvessel integrity within the neurovascular unit during focal cerebral ischemia
    J Cereb Blood Flow Metab (2015) 35, 1888-1900. PubMed  Europe PubMed DOI
  222. Hashimoto,Y., Kondo,C. and Katunuma,N.
    An active 32-kDa cathepsin L is secreted directly from HT 1080 fibrosarcoma cells and not via lysosomal exocytosis
    PLoS ONE (2015) 10, e0145067-e0145067. PubMed  Europe PubMed DOI
  223. Hou,L., Cooley,J., Swanson,R., Ong,P.C., Pike,R.N., Bogyo,M., Olson,S.T. and Remold-O'Donnell,E.
    The protease cathepsin L regulates Th17 cell differentiation
    J Autoimmun (2015) 65, 56-63. PubMed  Europe PubMed DOI
  224. Korenc,M., Lenarcic,B. and Novinec,M.
    Human cathepsin L, a papain-like collagenase without proline specificity
    FEBS J (2015) 282, 4328-4340. PubMed  Europe PubMed DOI
  225. McGlinchey,R.P. and Lee,J.C.
    Cysteine cathepsins are essential in lysosomal degradation of alpha-synuclein
    Proc Natl Acad Sci U S A (2015) 112, 9322-9327. PubMed  Europe PubMed DOI  P
  226. Ofori,L.O., Withana,N.P., Prestwood,T.R., Verdoes,M., Brady,J.J., Winslow,M.M., Sorger,J. and Bogyo,M.
    Design of protease activated optical contrast agents that exploit a latent lysosomotropic effect for use in fluorescence-guided surgery
    ACS Chem Biol (2015) 10, 1977-1988. PubMed  Europe PubMed DOI  L
  227. Parker,E.N., Song,J., Kishore Kumar,G.D., Odutola,S.O., Chavarria,G.E., Charlton-Sevcik,A.K., Strecker,T.E., Barnes,A.L., Sudhan,D.R., Wittenborn,T.R., Siemann,D.W., Horsman,M.R., Chaplin,D.J., Trawick,M.L. and Pinney,K.G.
    Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L
    Bioorg Med Chem (2015) 23, 6974-6992. PubMed  Europe PubMed DOI  I
  228. Rodrigues,T., Lin,Y.C., Hartenfeller,M., Renner,S., Lim,Y.F. and Schneider,G.
    Repurposing de novo designed entities reveals phosphodiesterase 3B and cathepsin L modulators
    Chem Commun (Camb) (2015) 51, 7478-7481. PubMed  Europe PubMed DOI
  229. Shen,J.D., Cai,Q.F., Yan,L.J., Du,C.H., Liu,G.M., Su,W.J., Ke,C. and Cao,M.J.
    Cathepsin L is an immune-related protein in Pacific abalone (Haliotis discus hannai) - purification and characterization
    Fish Shellfish Immunol (2015) 47, 986-995. PubMed  Europe PubMed DOI
  230. Sudhan,D.R. and Siemann,D.W.
    Cathepsin L targeting in cancer treatment
    Pharmacol Ther (2015) 155, 105-116. PubMed  Europe PubMed DOI
  231. Sun,B.G. and Hu,Y.H.
    Identification, mRNA expression profiling and activity characterization of cathepsin L from red drum (Sciaenops ocellatus)
    Fish Physiol Biochem (2015) 41, 1463-1473. PubMed  Europe PubMed DOI
  232. Vizovisek,M., Vidmar,R., Van Quickelberghe,E., Impens,F., Andjelkovic,U., Sobotic,B., Stoka,V., Gevaert,K., Turk,B. and Fonovic,M.
    Fast profiling of protease specificity reveals similar substrate specificities for cathepsins K, L and S
    Proteomics (2015) 15, 2479-2490. PubMed  Europe PubMed DOI  P
  233. Wang,H., Sang,N., Zhang,C., Raghupathi,R., Tanzi,R.E. and Saunders,A.
    Cathepsin L mediates the degradation of novel APP C-terminal fragments
    Biochemistry (2015) 54, 2806-2816. PubMed  Europe PubMed DOI  I
  234. Wang,R., Song,L., Su,B., Zhao,H., Zhang,D., Peatman,E. and Li,C.
    Mucosal expression signatures of two cathepsin L in channel catfish (Ictalurus punctatus) following bacterial challenge
    Fish Shellfish Immunol (2015) 47, 582-589. PubMed  Europe PubMed DOI
  235. Yang,N., Wang,P., Wang,W.J., Song,Y.Z. and Liang,Z.Q.
    Inhibition of cathepsin L sensitizes human glioma cells to ionizing radiation in vitro through NF-kappaB signaling pathway
    Acta Pharmacol Sin (2015) 36, 400-410. PubMed  Europe PubMed DOI  I
  236. Zhang,Q., Han,M., Wang,W., Song,Y., Chen,G., Wang,Z. and Liang,Z.
    Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor-beta-mediated epithelial-mesenchymal transition
    Oncol Rep (2015) 33, 1851-1859. PubMed  Europe PubMed DOI
  237. 2014
  238. Chua,K.C., Pietsch,M., Zhang,X., Hautmann,S., Chan,H.Y., Bruning,J.B., Gutschow,M. and Abell,A.D.
    Macrocyclic protease inhibitors with reduced peptide character
    Angew Chem Int Ed Engl (2014) 53, 7828-7831. PubMed  Europe PubMed DOI  I
  239. Dana,D., De,S., Rathod,P., Davalos,A.R., Novoa,D.A., Paroly,S., Torres,V.M., Afzal,N., Lankalapalli,R.S., Rotenberg,S.A., Chang,E.J., Subramaniam,G. and Kumar,S.
    Development of a highly potent, selective, and cell-active Inhibitor of cysteine cathepsin L - a hybrid design approach
    Chem Commun (Camb) (2014) 50, 10875-10878. PubMed  Europe PubMed DOI  I
  240. Duarte,L.F., Young,A.R., Wang,Z., Wu,H.A., Panda,T., Kou,Y., Kapoor,A., Hasson,D., Mills,N.R., Ma'ayan,A., Narita,M. and Bernstein,E.
    Histone H3.3 and its proteolytically processed form drive a cellular senescence programme
    Nat Commun (2014) 5, 5210-5210. PubMed  Europe PubMed DOI  PMC  EPMC
  241. Elshabrawy,H.A., Fan,J., Haddad,C.S., Ratia,K., Broder,C.C., Caffrey,M. and Prabhakar,B.S.
    Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay
    J Virol (2014) 88, 4353-4365. PubMed  Europe PubMed DOI  I
  242. Hu,X., Hu,X., Hu,B., Wen,C., Xie,Y., Wu,D., Tao,Z., Li,A. and Gao,Q.
    Molecular cloning and characterization of cathepsin L from freshwater mussel, Cristaria plicata
    Fish Shellfish Immunol (2014) 40, 446-454. PubMed  Europe PubMed DOI
  243. Kumaresan,V., Bhatt,P., Palanisamy,R., Gnanam,A.J., Pasupuleti,M. and Arockiaraj,J.
    A murrel cysteine protease, cathepsin L: Bioinformatics characterization, gene expression and proteolytic activity
    Biologia (2014) 69, 395-406. DOI
  244. Legowska,M., Wysocka,M., Burster,T., Pikula,M., Rolka,K. and Lesner,A.
    Ultrasensitive internally quenched substrates of human cathepsin L
    Anal Biochem (2014) 466, 30-37. PubMed  Europe PubMed DOI  A
  245. Miller,B., Friedman,A.J., Choi,H., Hogan,J., McCammon,J.A., Hook,V. and Gerwick,W.H.
    The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L
    J Nat Prod (2014) 77, 92-99. PubMed  Europe PubMed DOI  I
  246. Muller,S., Faulhaber,A., Sieber,C., Pfeifer,D., Hochberg,T., Gansz,M., Deshmukh,S.D., Dauth,S., Brix,K., Saftig,P., Peters,C., Henneke,P. and Reinheckel,T.
    The endolysosomal cysteine cathepsins L and K are involved in macrophage-mediated clearance of Staphylococcus aureus and the concomitant cytokine induction
    FASEB J (2014) 28, 162-175. PubMed  Europe PubMed DOI
  247. Pietra,D., Borghini,A., Ricci,C. and Bianucci,A.M.
    Enzyme kinetics studies on 29-kDa human liver cathepsin L
    Chem Biol Drug Des (2014) 84, 648-658. PubMed  Europe PubMed DOI
  248. Ramalho,S.D., De Sousa,L.R., Nebo,L., Maganhi,S.H., Caracelli,I., Zukerman-Schpector,J., Lima,M.I., Alves,M.F., da Silva,M.F., Fernandes,J.B. and Vieira,P.C.
    Triterpenoids as novel natural inhibitors of human cathepsin L
    Chem Biodivers (2014) 11, 1354-1363. PubMed  Europe PubMed DOI  I
  249. Shivanna,V., Kim,Y. and Chang,K.O.
    Endosomal acidification and cathepsin L activity is required for calicivirus replication
    Virology (2014) 464-465, 287-295. PubMed  Europe PubMed DOI
  250. Tholen,M., Hillebrand,L.E., Tholen,S., Sedelmeier,O., Arnold,S.J. and Reinheckel,T.
    Out-of-frame start codons prevent translation of truncated nucleo-cytosolic cathepsin L in vivo
    Nat Commun (2014) 5, 4931-4931. PubMed  Europe PubMed DOI
  251. Tholen,S., Biniossek,M.L., Gansz,M., Ahrens,T.D., Schlimpert,M., Kizhakkedathu,J.N., Reinheckel,T. and Schilling,O.
    Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis
    Cell Mol Life Sci (2014) 71, 899-916. PubMed  Europe PubMed DOI  K
  252. 2013
  253. Arockiaraj,J., Gnanam,A.J., Muthukrishnan,D., Thirumalai,M.K., Pasupuleti,M., Milton,J. and Kasi,M.
    Macrobrachium rosenbergii cathepsin L: molecular characterization and gene expression in response to viral and bacterial infections
    Microbiol Res (2013) 168, 569-579. PubMed  Europe PubMed DOI
  254. Badano,M.N., Camicia,G.L., Lombardi,G., Maglioco,A., Cabrera,G., Costa,H., Meiss,R.P., Piazzon,I. and Nepomnaschy,I.
    B-cell lymphopoiesis is regulated by cathepsin L
    PLoS ONE (2013) 8, e61347-e61347. PubMed  Europe PubMed DOI  PMC  EPMC
  255. Baek,K.H., Karki,R., Lee,E.S., Na,Y. and Kwon,Y.
    Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors
    Bioorg Chem (2013) 51, 24-30. PubMed  Europe PubMed DOI  I
  256. Brocklehurst,K. and Philpott,M.P.
    Cysteine proteases: mode of action and role in epidermal differentiation
    Cell Tissue Res (2013) 351, 237-244. PubMed  Europe PubMed DOI
  257. Ehmke,V., Winkler,E., Banner,D.W., Haap,W., Schweizer,W.B., Rottmann,M., Kaiser,M., Freymond,C., Schirmeister,T. and Diederich,F.
    Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L
    ChemMedChem (2013) 8, 967-975. PubMed  Europe PubMed DOI  I
  258. Grotsky,D.A., Gonzalez-Suarez,I., Novell,A., Neumann,M.A., Yaddanapudi,S.C., Croke,M., Martinez-Alonso,M., Redwood,A.B., Ortega-Martinez,S., Feng,Z., Lerma,E., Ramon,Y.C., Zhang,J., Matias-Guiu,X., Dusso,A. and Gonzalo,S.
    BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells
    J Cell Biol (2013) 200, 187-202. PubMed  Europe PubMed DOI  PMC  EPMC
  259. Niu,D., Jin,K., Wang,L., Feng,B. and Li,J.
    Molecular characterization and expression analysis of four cathepsin L genes in the razor clam, Sinonovacula constricta
    Fish Shellfish Immunol (2013) 35, 581-588. PubMed  Europe PubMed DOI
  260. Ohkouchi,S., Shibata,M., Sasaki,M., Koike,M., Safig,P., Peters,C., Nagata,S. and Uchiyama,Y.
    Biogenesis and proteolytic processing of lysosomal DNase II
    PLoS ONE (2013) 8, e59148-e59148. PubMed  Europe PubMed DOI  PMC  EPMC
  261. Song,J., Jones,L.M., Chavarria,G.E., Charlton-Sevcik,A.K., Jantz,A., Johansen,A., Bayeh,L., Soeung,V., Snyder,L.K., Lade,S.D., Jr., Chaplin,D.J., Trawick,M.L. and Pinney,K.G.
    Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks
    Bioorg Med Chem Lett (2013) 23, 2801-2807. PubMed  Europe PubMed DOI  I
  262. Tholen,S., Biniossek,M.L., Gansz,M., Gomez-Auli,A., Bengsch,F., Noel,A., Kizhakkedathu,J.N., Boerries,M., Busch,H., Reinheckel,T. and Schilling,O.
    Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome
    Mol Cell Proteomics (2013) 12, 611-625. PubMed  Europe PubMed DOI  K
  263. Torkar,A., Lenarcic,B., Lah,T., Dive,V. and Devel,L.
    Identification of new peptide amides as selective cathepsin L inhibitors: The first step towards selective irreversible inhibitors?
    Bioorg Med Chem Lett (2013) 23, 2968-2973. PubMed  Europe PubMed DOI  I
  264. Wang,Y.R., Qin,S., Han,R., Wu,J.C., Liang,Z.Q., Qin,Z.H. and Wang,Y.
    Cathepsin L plays a role in quinolinic acid-induced NF-Kappab activation and excitotoxicity in rat striatal neurons
    PLoS ONE (2013) 8, e75702-e75702. PubMed  Europe PubMed DOI  PMC  EPMC  I
  265. Wei,D.H., Jia,X.Y., Liu,Y.H., Guo,F.X., Tang,Z.H., Li,X.H., Wang,Z., Liu,L.S., Wang,G.X., Jian,Z.S. and Ruan,C.G.
    Cathepsin L stimulates autophagy and inhibits apoptosis of ox-LDL-induced endothelial cells: potential role in atherosclerosis
    Int J Mol Med (2013) 31, 400-406. PubMed  Europe PubMed DOI
  266. Xu,X., Greenland,J., Baluk,P., Adams,A., Bose,O., McDonald,D.M. and Caughey,G.H.
    Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis
    Am J Respir Cell Mol Biol (2013) 49, 437-444. PubMed  Europe PubMed DOI
  267. 2012
  268. Benavides,F., Perez,C., Blando,J., Contreras,O., Shen,J., Coussens,L.M., Fischer,S.M., Kusewitt,D.F., Digiovanni,J. and Conti,C.J.
    Protective role of cathepsin L in mouse skin carcinogenesis
    Mol Carcinog (2012) 51, 352-361. PubMed  Europe PubMed DOI  M
  269. Chavarria,G.E., Horsman,M.R., Arispe,W.M., Kumar,G.D., Chen,S.E., Strecker,T.E., Parker,E.N., Chaplin,D.J., Pinney,K.G. and Trawick,M.L.
    Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L
    Eur J Med Chem (2012) 58, 568-572. PubMed  Europe PubMed DOI  I
  270. Ehmke,V., Quinsaat,J.E., Rivera-Fuentes,P., Heindl,C., Freymond,C., Rottmann,M., Brun,R., Schirmeister,T. and Diederich,F.
    Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors
    Org Biomol Chem (2012) 10, 5764-5768. PubMed  Europe PubMed DOI  I
  271. Gnirss,K., Kuhl,A., Karsten,C., Glowacka,I., Bertram,S., Kaup,F., Hofmann,H. and Pohlmann,S.
    Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression
    Virology (2012) 424, 3-10. PubMed  Europe PubMed DOI
  272. Hook,V., Funkelstein,L., Wegrzyn,J., Bark,S., Kindy,M. and Hook,G.
    Cysteine cathepsins in the secretory vesicle produce active peptides: cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease
    Biochim Biophys Acta (2012) 1824, 89-104. PubMed  Europe PubMed DOI
  273. Hook,V.Y.H.
    Prohormone thiol protease
    [ISSN:978-0-12-407743-0] (2012) 3, 1817-1821. DOI
  274. Hu,Y., Ji,R., Jiang,H., Zhang,J., Chen,J. and Ye,X.
    Participation of cathepsin L in modori phenomenon in carp (Cyprinus carpio) surimi gel
    Food Chem (2012) 134, 2014-2020. PubMed  Europe PubMed DOI
  275. Kirschke,H.
    Cathepsin L
    [ISSN:978-0-12-407743-0] (2012) 3, 1808-1817. DOI
  276. Liang,J.Z., Rao,Y.Z., Lun,Z.R. and Yang,T.B.
    Cathepsin L in the orange-spotted grouper, Epinephelus coioides: molecular cloning and gene expression after a Vibrio anguillarum challenge
    Fish Physiol Biochem (2012) 38, 1795-1806. PubMed  Europe PubMed DOI
  277. Marques,E.F., Bueno,M.A., Duarte,P.D., Silva,L.R., Martinelli,A.M., Dos Santos,C.Y., Severino,R.P., Bromme,D., Vieira,P.C. and Correa,A.G.
    Evaluation of synthetic acridones and 4-quinolinones as potent inhibitors of cathepsins L and V
    Eur J Med Chem (2012) 54, 10-21. PubMed  Europe PubMed DOI  I
  278. Mbewe-Campbell,N., Wei,Z., Zhang,K., Friese,R.S., Mahata,M., Schork,A.J., Rao,F., Chiron,S., Biswas,N., Kim,H.S., Mahata,S.K., Waalen,J., Nievergelt,C.M., Hook,V.Y. and O'Connor,D.T.
    Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure
    J Hypertens (2012) 30, 1961-1969. PubMed  Europe PubMed DOI
  279. Morin,V., Sanchez-Rubio,A., Aze,A., Iribarren,C., Fayet,C., Desdevises,Y., Garcia-Huidobro,J., Imschenetzky,M., Puchi,M. and Geneviere,A.M.
    The protease degrading sperm histones post-fertilization in sea urchin eggs is a nuclear cathepsin L that is further required for embryo development
    PLoS ONE (2012) 7, e46850-e46850. PubMed  Europe PubMed DOI  PMC  EPMC
  280. Na,Z., Li,L., Uttamchandani,M. and Yao,S.Q.
    Microarray-guided discovery of two-photon (2P) small molecule probes for live-cell imaging of cysteinyl cathepsin activities
    Chem Commun (Camb) (2012) 48, 7304-7306. PubMed  Europe PubMed DOI  I
  281. Reif,M.M., Mach,L. and Oostenbrink,C.
    Molecular insight into propeptide-protein interactions in cathepsins L and O
    Biochemistry (2012) 51, 8636-8653. PubMed  Europe PubMed DOI
  282. Schurigt,U., Eilenstein,R., Gajda,M., Leipner,C., Sevenich,L., Reinheckel,T., Peters,C., Wiederanders,B. and Brauer,R.
    Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment
    Inflamm Res (2012) 61, 1021-1029. PubMed  Europe PubMed DOI
  283. Song,J., Jones,L.M., Kumar,G.D.K., Conner,E.S., Bayeh,L., Chavarria,G.E., Charlton-Sevcik,A.K., Chen,S.E., Chaplin,D.J., Trawick,M.L. and Pinney,K.G.
    Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L
    ACS Med Chem Lett (2012) 3, 450-453. PubMed  Europe PubMed DOI  I
  284. Torkar,A., Bregant,S., Devel,L., Novinec,M., Lenarcic,B., Lah,T. and Dive,V.
    A novel photoaffinity-based probe for selective detection of cathepsin L active form
    Chembiochem (2012) 13, 2616-2621. PubMed  Europe PubMed DOI
  285. Yamaguchi,M., Date,A., Sasaki,M., Makino,T. and Shimizu,T.
    Noninvasive biosensor for cathepsin L in the stratum corneum
    Skin Res Technol (2012) 18, 332-338. PubMed  Europe PubMed DOI  A
  286. 2011
  287. Adams-Cioaba,M.A., Krupa,J.C., Xu,C., Mort,J.S. and Min,J.
    Structural basis for the recognition and cleavage of histone H3 by cathepsin L
    Nat Commun (2011) 2, 197-197. PubMed  Europe PubMed DOI  S
  288. Biniossek,M.L., Nagler,D.K., Becker-Pauly,C. and Schilling,O.
    Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S
    J Proteome Res (2011) 10, 5363-5373. PubMed  Europe PubMed DOI  P
  289. Chen,L., Zhang,M. and Sun,L.
    Identification and expressional analysis of two cathepsins from half-smooth tongue sole (Cynoglossus semilaevis)
    Fish Shellfish Immunol (2011) 31, 1270-1277. PubMed  Europe PubMed DOI
  290. Chung,J.H., Im,E.K., Jin,T., Lee,S.M., Kim,S.H., Choi,E.Y., Shin,M.J., Lee,K.H. and Jang,Y.
    Cathepsin L derived from skeletal muscle cells transfected with bFGF promotes endothelial cell migration
    Exp Mol Med (2011) 43, 179-188. PubMed  Europe PubMed DOI
  291. Funkelstein,L. and Hook,V.
    The novel role of cathepsin L for neuropeptide production illustrated by research strategies in chemical biology with protease gene knockout and expression
    Methods Mol Biol (2011) 768, 107-125. PubMed  Europe PubMed DOI
  292. Gonzalez-Suarez,I., Redwood,A.B., Grotsky,D.A., Neumann,M.A., Cheng,E.H., Stewart,C.L., Dusso,A. and Gonzalo,S.
    A new pathway that regulates 53BP1 stability implicates cathepsin L and vitamin D in DNA repair
    EMBO J (2011) 30, 3383-3396. PubMed  Europe PubMed DOI
  293. Hardegger,L.A., Kuhn,B., Spinnler,B., Anselm,L., Ecabert,R., Stihle,M., Gsell,B., Thoma,R., Diez,J., Benz,J., Plancher,J.M., Hartmann,G., Isshiki,Y., Morikami,K., Shimma,N., Haap,W., Banner,D.W. and Diederich,F.
    Halogen bonding at the active sites of human cathepsin L and MEK1 kinase: efficient interactions in different environments
    ChemMedChem (2011) 6, 2048-2054. PubMed  Europe PubMed DOI  S
  294. Le,Q.T., Min,H.K., Xia,H.Z., Fukuoka,Y., Katunuma,N. and Schwartz,L.B.
    Promiscuous processing of human alphabeta-protryptases by cathepsins L, B, and C
    J Immunol (2011) 186, 7136-7143. PubMed  Europe PubMed DOI
  295. Savalas,L.R., Gasnier,B., Damme,M., Lubke,T., Wrocklage,C., Debacker,C., Jezegou,A., Reinheckel,T., Hasilik,A., Saftig,P. and Schroder,B.
    Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L
    Biochem J (2011) 439, 113-128. PubMed  Europe PubMed DOI
  296. Schechter,I. and Ziv,E.
    Cathepsins S, B and L with aminopeptidases display beta-secretase activity associated with the pathogenesis of Alzheimer's disease
    Biol Chem (2011) 392, 555-569. PubMed  Europe PubMed DOI
  297. Shenoy,R.T. and Sivaraman,J.
    Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors
    J Struct Biol (2011) 173, 14-19. PubMed  Europe PubMed DOI  I
  298. Sun,J., Sukhova,G.K., Zhang,J., Chen,H., Sjoberg,S., Libby,P., Xiang,M., Wang,J., Peters,C., Reinheckel,T. and Shi,G.P.
    Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice
    Arterioscler Thromb Vasc Biol (2011) 31, 2500-2508. PubMed  Europe PubMed DOI  K
  299. Sun,M., Chen,M., Liu,Y., Fukuoka,M., Zhou,K., Li,G., Dawood,F., Gramolini,A. and Liu,P.P.
    Cathepsin-L contributes to cardiac repair and remodelling post-infarction
    Cardiovasc Res (2011) 89, 374-383. PubMed  Europe PubMed DOI  K
  300. Tholen,S., Biniossek,M.L., Gessler,A.L., Muller,S., Weisser,J., Kizhakkedathu,J.N., Reinheckel,T. and Schilling,O.
    Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts
    Biol Chem (2011) 392, 961-971. PubMed  Europe PubMed DOI  K
  301. Whang,I., De Zoysa,M., Nikapitiya,C., Lee,Y., Kim,Y., Lee,S., Oh,C., Jung,S.J., Oh,M.J., Choi,C.Y., Yeo,S.Y., Kim,B.S., Kim,S.J. and Lee,J.
    Molecular characterization and expression analysis of cathepsin B and L cysteine proteases from rock bream (Oplegnathus fasciatus)
    Fish Shellfish Immunol (2011) 30, 763-772. PubMed  Europe PubMed DOI
  302. Xiang,B., Fei,X., Zhuang,W., Fang,Y., Qin,Z. and Liang,Z.
    Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells
    Brain Res (2011) 1387, 29-38. PubMed  Europe PubMed DOI  I
  303. 2010
  304. Ahn,S.J., Sung,J.H., Kim,N.Y., Lee,A.R., Jeon,S.J., Lee,J.S., Kim,J.K., Chung,J.K. and Lee,H.H.
    Molecular cloning, expression, and characterization of cathepsin L from mud loach (Misgurnus mizolepis)
    Appl Biochem Biotechnol (2010) 162, 1858-1871. PubMed  Europe PubMed DOI
  305. Ceru,S., Konjar,S., Maher,K., Repnik,U., Krizaj,I., Bencina,M., Renko,M., Nepveu,A., Zerovnik,E., Turk,B. and Kopitar-Jerala,N.
    Stefin B interacts with histones and cathepsin L in the nucleus
    J Biol Chem (2010) 285, 10078-10086. PubMed  Europe PubMed DOI
  306. Dennemarker,J., Lohmuller,T., Mayerle,J., Tacke,M., Lerch,M.M., Coussens,L.M., Peters,C. and Reinheckel,T.
    Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis
    Oncogene (2010) 29, 1611-1621. PubMed  Europe PubMed DOI  K
  307. Dennemarker,J., Lohmuller,T., Muller,S., Aguilar,S.V., Tobin,D.J., Peters,C. and Reinheckel,T.
    Impaired turnover of autophagolysosomes in cathepsin L deficiency
    Biol Chem (2010) 391, 913-922. PubMed  Europe PubMed DOI  K
  308. Fortenberry,Y.M., Brandal,S., Bialas,R.C. and Church,F.C.
    Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migration
    Biochim Biophys Acta (2010) 1800, 580-590. PubMed  Europe PubMed DOI
  309. Frizler,M., Stirnberg,M., Sisay,M.T. and Gutschow,M.
    Development of nitrile-based peptidic inhibitors of cysteine cathepsins
    Curr Top Med Chem (2010) 10, 294-322. PubMed  Europe PubMed DOI  T  I
  310. Funkelstein,L., Beinfeld,M., Minokadeh,A., Zadina,J. and Hook,V.
    Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides
    Neuropeptides (2010) 44, 457-466. PubMed  Europe PubMed DOI
  311. Higgins,W.J., Fox,D.M., Kowalski,P.S., Nielsen,J.E. and Worrall,D.M.
    Heparin enhances serpin inhibition of the cysteine protease cathepsin L
    J Biol Chem (2010) 285, 3722-3729. PubMed  Europe PubMed DOI
  312. Hood,C.L., Abraham,J., Boyington,J.C., Leung,K., Kwong,P.D. and Nabel,G.J.
    Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity
    J Virol (2010) 84, 2972-2982. PubMed  Europe PubMed DOI
  313. Hsing,L.C., Kirk,E.A., McMillen,T.S., Hsiao,S.H., Caldwell,M., Houston,B., Rudensky,A.Y. and LeBoeuf,R.C.
    Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse
    J Autoimmun (2010) 34, 96-104. PubMed  Europe PubMed DOI
  314. Hu,Y., Morioka,K. and Itoh,Y.
    Participation of cysteine protease cathepsin L in the gel disintegration of red bulleye (Priacanthus macracanthus) surimi gel paste
    J Sci Food Agric (2010) 90, 370-375. PubMed  Europe PubMed DOI
  315. Kishore Kumar,G.D., Chavarria,G.E., Charlton-Sevcik,A.K., Arispe,W.M., Macdonough,M.T., Strecker,T.E., Chen,S.E., Siim,B.G., Chaplin,D.J., Trawick,M.L. and Pinney,K.G.
    Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors
    Bioorg Med Chem Lett (2010) 20, 1415-1419. PubMed  Europe PubMed DOI  I
  316. Kistler,A.D., Peev,V., Forst,A.L., El Hindi,S., Altintas,M.M. and Reiser,J.
    Enzymatic disease of the podocyte
    Pediatr Nephrol (2010) 25, 1017-1023. PubMed  Europe PubMed DOI
  317. Konjar,S., Sutton,V.R., Hoves,S., Repnik,U., Yagita,H., Reinheckel,T., Peters,C., Turk,V., Turk,B., Trapani,J.A. and Kopitar-Jerala,N.
    Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L
    Immunology (2010) 131, 257-267. PubMed  Europe PubMed DOI
  318. Kumar,G.D., Chavarria,G.E., Charlton-Sevcik,A.K., Yoo,G.K., Song,J., Strecker,T.E., Siim,B.G., Chaplin,D.J., Trawick,M.L. and Pinney,K.G.
    Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L
    Bioorg Med Chem Lett (2010) 20, 6610-6615. PubMed  Europe PubMed DOI  I
  319. Lankelma,J.M., Voorend,D.M., Barwari,T., Koetsveld,J., Van der Spek,A.H., De Porto,A.P., Van Rooijen,G. and Van Noorden,C.J.
    Cathepsin L, target in cancer treatment?
    Life Sci (2010) 86, 225-233. PubMed  Europe PubMed DOI
  320. Minokadeh,A., Funkelstein,L., Toneff,T., Hwang,S.R., Beinfeld,M., Reinheckel,T., Peters,C., Zadina,J. and Hook,V.
    Cathepsin L participates in dynorphin production in brain cortex, illustrated by protease gene knockout and expression
    Mol Cell Neurosci (2010) 43, 98-107. PubMed  Europe PubMed DOI  K
  321. Sansanwal,P., Shukla,A.A., Das,T.K. and Chauhan,S.S.
    Truncated human cathepsin L, encoded by a novel splice variant, exhibits altered subcellular localization and cytotoxicity
    Protein Pept Lett (2010) 17, 238-245. PubMed  Europe PubMed DOI  R
  322. Sevenich,L., Hagemann,S., Stoeckle,C., Tolosa,E., Peters,C. and Reinheckel,T.
    Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice
    Biochimie (2010) 92, 1674-1680. PubMed  Europe PubMed DOI
  323. Shah,P.P., Wang,T., Kaletsky,R.L., Myers,M.C., Purvis,J.E., Jing,H., Huryn,D.M., Greenbaum,D.C., Smith,A.B., III, Bates,P. and Diamond,S.L.
    A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells
    Mol Pharmacol (2010) 78, 319-324. PubMed  Europe PubMed DOI  I
  324. Shimada,N., Ohno-Matsui,K., Iseki,S., Koike,M., Uchiyama,Y., Wang,J., Yoshida,T., Sato,T., Peters,C., Mochizuki,M. and Morita,I.
    Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization
    Am J Pathol (2010) 176, 2571-2580. PubMed  Europe PubMed DOI
  325. Wartmann,T., Mayerle,J., Kahne,T., Sahin-Toth,M., Ruthenburger,M., Matthias,R., Kruse,A., Reinheckel,T., Peters,C., Weiss,F.U., Sendler,M., Lippert,H., Schulz,H.U., Aghdassi,A., Dummer,A., Teller,S., Halangk,W. and Lerch,M.M.
    Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice
    Gastroenterology (2010) 138, 726-737. PubMed  Europe PubMed DOI
  326. Yamada,A., Ishimaru,N., Arakaki,R., Katunuma,N. and Hayashi,Y.
    Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity
    PLoS ONE (2010) 5, e12894-e12894. PubMed  Europe PubMed DOI  PMC  EPMC  I
  327. Yamazaki,Y., Kamei,Y., Sugita,S., Akaike,F., Kanai,S., Miura,S., Hirata,Y., Troen,B.R., Kitamura,T., Nishino,I., Suganami,T., Ezaki,O. and Ogawa,Y.
    The cathepsin L gene is a direct target of FOXO1 in skeletal muscle
    Biochem J (2010) 427, 171-178. PubMed  Europe PubMed DOI
  328. Zeeuwen,P.L., van Vlijmen-Willems,I.M., Cheng,T., Rodijk-Olthuis,D., Hitomi,K., Hara-Nishimura,I., John,S., Smyth,N., Reinheckel,T., Hendriks,W.J. and Schalkwijk,J.
    The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea
    FASEB J (2010) 24, 3744-3755. PubMed  Europe PubMed DOI  K
  329. 2009
  330. Ahimbisibwe,J.B., Inoue,K. and Aoki,T.
    Detection of cathepsin L in red cell membranes from fish blood
    Fish Sci (2009) 76, 155-159. DOI
  331. Asaad,N., Bethel,P.A., Coulson,M.D., Dawson,J.E., Ford,S.J., Gerhardt,S., Grist,M., Hamlin,G.A., James,M.J., Jones,E.V., Karoutchi,G.I., Kenny,P.W., Morley,A.D., Oldham,K., Rankine,N., Ryan,D., Wells,S.L., Wood,L., Augustin,M., Krapp,S., Simader,H. and Steinbacher,S.
    Dipeptidyl nitrile inhibitors of cathepsin L
    Bioorg Med Chem Lett (2009) 19, 4280-4283. PubMed  Europe PubMed DOI  I
  332. Beinfeld,M.C., Funkelstein,L., Foulon,T., Cadel,S., Kitagawa,K., Toneff,T., Reinheckel,T., Peters,C. and Hook,V.
    Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies
    Peptides (2009) 30, 1882-1891. PubMed  Europe PubMed DOI  PMC  EPMC  K  I
  333. Bethel,P.A., Gerhardt,S., Jones,E.V., Kenny,P.W., Karoutchi,G.I., Morley,A.D., Oldham,K., Rankine,N., Augustin,M., Krapp,S., Simader,H. and Steinbacher,S.
    Design of selective cathepsin inhibitors
    Bioorg Med Chem Lett (2009) 19, 4622-4625. PubMed  Europe PubMed DOI  I
  334. Biswas,N., Rodriguez-Flores,J.L., Courel,M., Gayen,J.R., Vaingankar,S.M., Mahata,M., Torpey,J.W., Taupenot,L., O'Connor,D.T. and Mahata,S.K.
    Cathepsin L colocalizes with chromogranin A in chromaffin vesicles to generate active peptides
    Endocrinology (2009) 150, 3547-3557. PubMed  Europe PubMed DOI  PMC  EPMC
  335. Fei,X.F., Qin,Z.H., Xiang,B., Li,L.Y., Han,F., Fukunaga,K. and Liang,Z.Q.
    Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine
    Brain Res (2009) 1264, 85-97. PubMed  Europe PubMed DOI
  336. Fonovic,U.P. and Kos,J.
    Efficient removal of cathepsin L from active cathepsin X using immunoprecipitation technique
    Acta Chim Slov (2009) 56, 985-988.
  337. Jordans,S., Jenko-Kokalj,S., Kuhl,N.M., Tedelind,S., Sendt,W., Bromme,D., Turk,D. and Brix,K.
    Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions
    BMC Biochem (2009) 10, 23-23. PubMed  Europe PubMed DOI  PMC  EPMC
  338. Liu,Y., Li,X., Peng,D., Tan,Z., Liu,H., Qing,Y., Xue,Y. and Shi,G.P.
    Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease
    Am J Cardiol (2009) 103, 476-481. PubMed  Europe PubMed DOI  PMC  EPMC
  339. Luft,F.C.
    From furless to heartless - unraveling the diverse functions of cathepsin L
    J Mol Med (Berl) (2009) 87, 225-227. PubMed  Europe PubMed DOI  K
  340. Rebbaa,A., Chu,F., Sudha,T., Gallati,C., Dier,U., Dyskin,E., Yalcin,M., Bianchini,C., Shaker,O. and Mousa,S.A.
    The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor
    Anticancer Res (2009) 29, 4473-4481. PubMed  Europe PubMed  I
  341. Rebbaa,A., Dyskin,E., Dier,E., Gallati,C., Honko,C., Simone,T., Yalcin,M., Sudha,T. and Mousa,S.A.
    Antiproliferative, antiangiogenesis, and reversal of chemoresistance by specific cathepsin L inhibitors
    J Clin Oncol (2009) 27, e14643-e14643. PubMed  Europe PubMed  I
  342. Schilling,K., Korner,A., Sehmisch,S., Kreusch,A., Kleint,R., Benedix,Y., Schlabrakowski,A. and Wiederanders,B.
    Selectivity of propeptide-enzyme interaction in cathepsin L-like cysteine proteases
    Biol Chem (2009) 390, 167-174. PubMed  Europe PubMed DOI
  343. See,V., Free,P., Cesbron,Y., Nativo,P., Shaheen,U., Rigden,D.J., Spiller,D.G., Fernig,D.G., White,M.R., Prior,I.A., Brust,M., Lounis,B. and Levy,R.
    Cathepsin L digestion of nanobioconjugates upon endocytosis
    ACS Nano (2009) 3, 2461-2468. PubMed  Europe PubMed DOI
  344. Shenoy,R.T., Chowdhury,S.F., Kumar,S., Joseph,L., Purisima,E.O. and Sivaraman,J.
    A combined crystallographic and molecular dynamics study of cathepsin L retrobinding inhibitors
    J Med Chem (2009) 52, 6335-6346. PubMed  Europe PubMed DOI  S  I
  345. Takahashi,K., Ueno,T., Tanida,I., Minematsu-Ikeguchi,N., Murata,M. and Kominami,E.
    Characterization of CAA0225, a novel inhibitor specific for cathepsin L, as a probe for autophagic proteolysis
    Biol Pharm Bull (2009) 32, 475-479. PubMed  Europe PubMed DOI  I
  346. Tang,Q., Cai,J., Shen,D., Bian,Z., Yan,L., Wang,Y.X., Lan,J., Zhuang,G.Q., Ma,W.Z. and Wang,W.
    Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling
    J Mol Med (Berl) (2009) 87, 249-260. PubMed  Europe PubMed DOI
  347. Ueno,T. and Takahashi,K.
    A cathepsin L-specific inhibitor preferentially inhibits degradation of autophagosomal LC3 and GABARAP in HeLa and Huh-7 cells
    Autophagy (2009) 5, 878-879. PubMed  Europe PubMed  I
  348. Visone,T., Charron,M. and Wright,W.W.
    Activation and repression domains within the promoter of the rat cathepsin L gene orchestrate Sertoli cell-specific and stage-specific gene transcription in transgenic mice
    Biol Reprod (2009) 81, 571-579. PubMed  Europe PubMed DOI
  349. Yoshii,H., Kamiyama,H., Minematsu,K., Goto,K., Mizota,T., Oishi,K., Katunuma,N., Yamamoto,N. and Kubo,Y.
    Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells
    Virology (2009) 394, 227-234. PubMed  Europe PubMed DOI  I
  350. 2008
  351. Abboud-Jarrous,G., Atzmon,R., Peretz,T., Palermo,C., Gadea,B.B., Joyce,J.A. and Vlodavsky,I.
    Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment
    J Biol Chem (2008) 283, 18167-18176. PubMed  Europe PubMed DOI  PMC  EPMC
  352. Bosch,B.J., Bartelink,W. and Rottier,P.J.
    Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide
    J Virol (2008) 82, 8887-8890. PubMed  Europe PubMed DOI  PMC  EPMC
  353. Chowdhury,S.F., Joseph,L., Kumar,S., Tulsidas,S.R., Bhat,S., Ziomek,E., Menard,R., Sivaraman,J. and Purisima,E.O.
    Exploring inhibitor binding at the S' subsites of cathepsin L
    J Med Chem (2008) 51, 1361-1368. PubMed  Europe PubMed DOI  S  I
  354. Duncan,E.M., Muratore-Schroeder,T.L., Cook,R.G., Garcia,B.A., Shabanowitz,J., Hunt,D.F. and Allis,C.D.
    Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation
    Cell (2008) 135, 284-294. PubMed  Europe PubMed DOI  PMC  EPMC  P
  355. Fairhead,M., Johnson,K.A., Kowatz,T., McMahon,S.A., Carter,L.G., Oke,M., Liu,H., Naismith,J.H. and van der Walle,C.F.
    Crystal structure and silica condensing activities of silicatein alpha-cathepsin L chimeras
    Chem Commun (Camb) (2008) 2008, 1765-1767. PubMed  Europe PubMed DOI  S
  356. Fairhead,M. and van der Walle,C.F.
    The heavy-light chain loop of human cathepsin-L modulates its activity and stability
    Protein Pept Lett (2008) 15, 47-53. PubMed  Europe PubMed DOI
  357. Fairhead,M., Kelly,S.M. and van der Walle,C.F.
    A heparin binding motif on the pro-domain of human procathepsin L mediates zymogen destabilization and activation
    Biochem Biophys Res Commun (2008) 366, 862-867. PubMed  Europe PubMed DOI
  358. Funkelstein,L., Toneff,T., Hwang,S.R., Reinheckel,T., Peters,C. and Hook,V.
    Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression
    J Neurochem (2008) 106, 384-391. PubMed  Europe PubMed DOI  PMC  EPMC  K
  359. Funkelstein,L., Toneff,T., Mosier,C., Hwang,S.R., Beuschlein,F., Lichtenauer,U.D., Reinheckel,T., Peters,C. and Hook,V.
    Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression
    J Biol Chem (2008) 283, 35652-35659. PubMed  Europe PubMed DOI  PMC  EPMC  I
  360. Hook,V., Funkelstein,L., Lu,D., Bark,S., Wegrzyn,J. and Hwang,S.R.
    Proteases for processing proneuropeptides into peptide neurotransmitters and hormones
    Annu Rev Pharmacol Toxicol (2008) 48, 393-423. PubMed  Europe PubMed DOI  PMC  EPMC
  361. Jean,D., Rousselet,N. and Frade,R.
    Cathepsin L expression is up-regulated by hypoxia in human melanoma cells: role of its 5'-untranslated region
    Biochem J (2008) 413, 125-134. PubMed  Europe PubMed DOI
  362. Myers,M.C., Shah,P.P., Diamond,S.L., Huryn,D.M. and Smith,A.B., III
    Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor
    Bioorg Med Chem Lett (2008) 18, 210-214. PubMed  Europe PubMed DOI  PMC  EPMC  I
  363. Myers,M.C., Shah,P.P., Beavers,M.P., Napper,A.D., Diamond,S.L., Smith,A.B., III and Huryn,D.M.
    Design, synthesis, and evaluation of inhibitors of cathepsin L: exploiting a unique thiocarbazate chemotype
    Bioorg Med Chem Lett (2008) 18, 3646-3651. PubMed  Europe PubMed DOI  PMC  EPMC  I
  364. Schaschke,N., Assfalg-Machleidt,I. and Machleidt,W.
    Inhibition of cathepsin L by epoxysuccinyl peptides simultaneously addressing active-site and remote-site regions
    Chembiochem (2008) 9, 1721-1724. PubMed  Europe PubMed DOI  I
  365. Shah,P.P., Myers,M.C., Beavers,M.P., Purvis,J.E., Jing,H., Grieser,H.J., Sharlow,E.R., Napper,A.D., Huryn,D.M., Cooperman,B.S., Smith,A.B., III and Diamond,S.L.
    Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L
    Mol Pharmacol (2008) 74, 34-41. PubMed  Europe PubMed DOI  PMC  EPMC  S  I
  366. Yadav,M.R., Shinde,A.K., Chouhan,B.S., Giridhar,R. and Menard,R.
    Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors
    J Enzyme Inhib Med Chem (2008) 23, 190-197. PubMed  Europe PubMed DOI  I
  367. Zhu,S., Wei,L., Yamasaki,K. and Gallo,R.L.
    Activation of cathepsin L by the cathelin-like domain of protegrin-3
    Mol Immunol (2008) 45, 2531-2536. PubMed  Europe PubMed DOI  PMC  EPMC
  368. 2007
  369. Boudreau,F., Lussier,C.R., Mongrain,S., Darsigny,M., Drouin,J.L., Doyon,G., Suh,E.R., Beaulieu,J.F., Rivard,N. and Perreault,N.
    Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia
    FASEB J (2007) 21, 3853-3865. PubMed  Europe PubMed DOI  K
  370. Burden,R.E., Snoddy,P., Jefferies,C.A., Walker,B. and Scott,C.J.
    Inhibition of cathepsin L-like proteases by cathepsin V propeptide
    Biol Chem (2007) 388, 541-545. PubMed  Europe PubMed DOI
  371. Charron,M., Chern,J.Y. and Wright,W.W.
    The cathepsin L first intron stimulates gene expression in rat Sertoli cells
    Biol Reprod (2007) 76, 813-824. PubMed  Europe PubMed DOI
  372. Goulet,B., Sansregret,L., Leduy,L., Bogyo,M., Weber,E., Chauhan,S.S. and Nepveu,A.
    Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation
    Mol Cancer Res (2007) 5, 899-907. PubMed  Europe PubMed DOI
  373. Hwang,S.R., Garza,C., Mosier,C., Toneff,T., Wunderlich,E., Goldsmith,P. and Hook,V.
    Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion
    J Biol Chem (2007) 282, 9556-9563. PubMed  Europe PubMed DOI
  374. Kramer,G., Paul,A., Kreusch,A., Schuler,S., Wiederanders,B. and Schilling,K.
    Optimized folding and activation of recombinant procathepsin L and S produced in Escherichia coli
    Protein Expr Purif (2007) 54, 147-156. PubMed  Europe PubMed DOI  E
  375. Mori,Y., Yamashita,T., Tanaka,Y., Tsuda,Y., Abe,T., Moriishi,K. and Matsuura,Y.
    Processing of capsid protein by cathepsin L plays a crucial role in replication of Japanese encephalitis virus in neural and macrophage cells
    J Virol (2007) 81, 8477-8487. PubMed  Europe PubMed DOI  PMC  EPMC
  376. Ruettger,A. and Wiederanders,B.
    Microplate assay for cathepsin detection in viable cells using derivatives of 4-methoxy-beta-naphthylamide
    Curr Protoc Protein Sci (2007) Unit 21.21, Unit 21.21- PubMed  Europe PubMed DOI  A
  377. Sever,S., Altintas,M.M., Nankoe,S.R., Moller,C.C., Ko,D., Wei,C., Henderson,J., del Re,E.C., Hsing,L., Erickson,A., Cohen,C.D., Kretzler,M., Kerjaschki,D., Rudensky,A., Nikolic,B. and Reiser,J.
    Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease
    J Clin Invest (2007) 117, 2095-2104. PubMed  Europe PubMed DOI  PMC  EPMC
  378. Spira,D., Stypmann,J., Tobin,D.J., Petermann,I., Mayer,C., Hagemann,S., Vasiljeva,O., Gunther,T., Schule,R., Peters,C. and Reinheckel,T.
    Cell type-specific functions of the lysosomal protease cathepsin L in the heart
    J Biol Chem (2007) 282, 37045-37052. PubMed  Europe PubMed DOI
  379. Stahl,S., Reinders,Y., Asan,E., Mothes,W., Conzelmann,E., Sickmann,A. and Felbor,U.
    Proteomic analysis of cathepsin B- and L-deficient mouse brain lysosomes
    Biochim Biophys Acta (2007) 1774, 1237-1246. PubMed  Europe PubMed DOI  K
  380. Tingaud-Sequeira,A. and Cerda,J.
    Phylogenetic relationships and gene expression pattern of three different cathepsin L (Ctsl) isoforms in zebrafish: Ctsla is the putative yolk processing enzyme
    Gene (2007) 386, 98-106. PubMed  Europe PubMed DOI
  381. Walz,M., Kellermann,S., Bylaite,M., Andree,B., Ruther,U., Paus,R., Kloepper,J.E., Reifenberger,J. and Ruzicka,T.
    Expression of the human cathepsin L inhibitor hurpin in mice: skin alterations and increased carcinogenesis
    Exp Dermatol (2007) 16, 715-723. PubMed  Europe PubMed DOI
  382. Yang,M., Zhang,Y., Pan,J., Sun,J., Liu,J., Libby,P., Sukhova,G.K., Doria,A., Katunuma,N., Peroni,O.D., Guerre-Millo,M., Kahn,B.B., Clement,K. and Shi,G.P.
    Cathepsin L activity controls adipogenesis and glucose tolerance
    Nat Cell Biol (2007) 9, 970-977. PubMed  Europe PubMed DOI  K  I
  383. Yang,Z. and Cox,J.L.
    Cathepsin L increases invasion and migration of B16 melanoma
    Cancer Cell Int (2007) 7, 8-8. PubMed  Europe PubMed DOI  PMC  EPMC
  384. 2006
  385. [YEAR:15-1-2006]Benavides,F., Perez,C., Blando,J., Guenet,J.L. and Conti,C.J.
    The radiation-induced nackt (nkt) allele is a loss-of-function mutation of the mouse cathepsin L gene
    J Immunol (15-1-2006) 176, 702-703. PubMed  Europe PubMed  M
  386. Bulynko,Y.A., Hsing,L.C., Mason,R.W., Tremethick,D.J. and Grigoryev,S.A.
    Cathepsin L stabilizes the histone modification landscape on the Y chromosome and pericentromeric heterochromatin
    Mol Cell Biol (2006) 26, 4172-4184. PubMed  Europe PubMed DOI  PMC  EPMC
  387. Caserman,S., Kenig,S., Sloane,B.F. and Lah,T.T.
    Cathepsin L splice variants in human breast cell lines
    Biol Chem (2006) 387, 629-634. PubMed  Europe PubMed DOI  R
  388. [YEAR:24-3-2006]Cheng,T., Hitomi,K., van Vlijmen-Willems,I.M., de Jongh,G.J., Yamamoto,K., Nishi,K., Watts,C., Reinheckel,T., Schalkwijk,J. and Zeeuwen,P.L.
    Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification
    J Biol Chem (24-3-2006) 281, 15893-15899. PubMed  Europe PubMed DOI
  389. [YEAR:6-3-2006]Choe,Y., Leonetti,F., Greenbaum,D.C., Lecaille,F., Bogyo,M., Bromme,D., Ellman,J.A. and Craik,C.S.
    Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities
    J Biol Chem (6-3-2006) 281, 12824-12832. PubMed  Europe PubMed DOI  P
  390. Goulet,B., Truscott,M. and Nepveu,A.
    A novel proteolytically processed CDP/Cux isoform of 90 kDa is generated by cathepsin L
    Biol Chem (2006) 387, 1285-1293. PubMed  Europe PubMed DOI
  391. Hashimoto,Y., Kondo,C., Kojima,T., Nagata,H., Moriyama,A., Hayakawa,T. and Katunuma,N.
    Significance of 32-kDa cathepsin L secreted from cancer cells
    Cancer Biother Radiopharm (2006) 21, 217-224. PubMed  Europe PubMed DOI
  392. [YEAR:31-10-2006]Jean,D., Rousselet,N. and Frade,R.
    Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms
    Oncogene (31-10-2006) 25, 1474-1484. PubMed  Europe PubMed DOI
  393. Linke,M., Gordon,R.E., Brillard,M., Lecaille,F., Lalmanach,G. and Bromme,D.
    Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins
    Biol Chem (2006) 387, 1295-1303. PubMed  Europe PubMed DOI  P
  394. [YEAR:13-12-2006]Liu,H., Yin,L., Zhang,N., Li,S. and Ma,C.
    Purification and characterization of cathepsin L from the muscle of silver carp (Hypophthalmichthys molitrix)
    J Agric Food Chem (13-12-2006) 54, 9584-9591. PubMed  Europe PubMed DOI
  395. [YEAR:24-6-2006]Liu,J., Sukhova,G.K., Yang,J.T., Sun,J., Ma,L., Ren,A., Xu,W.H., Fu,H., Dolganov,G.M., Hu,C., Libby,P. and Shi,G.P.
    Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells
    Atherosclerosis (24-6-2006) 184, 302-311. PubMed  Europe PubMed DOI
  396. Petermann,I., Mayer,C., Stypmann,J., Biniossek,M.L., Tobin,D.J., Engelen,M.A., Dandekar,T., Grune,T., Schild,L., Peters,C. and Reinheckel,T.
    Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice
    FASEB J (2006) 20, 1266-1268. PubMed  Europe PubMed DOI  K
  397. Ruttger,A., Mollenhauer,J., Loser,R., Gutschow,M. and Wiederanders,B.
    Microplate assay for quantitative determination of cathepsin activities in viable cells using derivatives of 4-methoxy-beta-naphthylamide
    Biotechniques (2006) 41, 469-473. PubMed  Europe PubMed DOI  A
  398. Sevenich,L., Pennacchio,L.A., Peters,C. and Reinheckel,T.
    Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice
    Biol Chem (2006) 387, 885-891. PubMed  Europe PubMed DOI  K
  399. [YEAR:25-8-2006]Vicik,R., Busemann,M., Gelhaus,C., Stiefl,N., Scheiber,J., Schmitz,W., Schulz,F., Mladenovic,M., Engels,B., Leippe,M., Baumann,K. and Schirmeister,T.
    Aziridide-based inhibitors of cathepsin L: synthesis, inhibition activity, and docking studies
    ChemMedChem (25-8-2006) 1, 1126-1141. PubMed  Europe PubMed DOI  I
  400. Zajc,I., Hreljac,I. and Lah,T.
    Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics
    Anticancer Res (2006) 26, 3357-3364. PubMed  Europe PubMed
  401. 2005
  402. [YEAR:10-2-2005]Gordon,P.V., Paxton,J.B., Kuemmerle,J.F. and Fox,N.S.
    A 14-kDa cathepsin L-derived carboxyl IGFBP-2 fragment is sequestered by cultured rat ileal crypt cells
    Am J Physiol Gastrointest Liver Physiol (10-2-2005) 289, G79-G87. PubMed  Europe PubMed DOI
  403. Koike,M., Shibata,M., Waguri,S., Yoshimura,K., Tanida,I., Kominami,E., Gotow,T., Peters,C., von Figura,K., Mizushima,N., Saftig,P. and Uchiyama,Y.
    Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease)
    Am J Pathol (2005) 167, 1713-1728. PubMed  Europe PubMed DOI  PMC  EPMC  K
  404. [YEAR:1-10-2005]Maehr,R., Mintern,J.D., Herman,A.E., Lennon-Dumenil,A.M., Mathis,D., Benoist,C. and Ploegh,H.L.
    Cathepsin L is essential for onset of autoimmune diabetes in NOD mice
    J Clin Invest (1-10-2005) 115, 2934-2943. PubMed  Europe PubMed DOI  PMC  EPMC
  405. [YEAR:3-11-2005]Marquis,R.W., James,I., Zeng,J., Trout,R.E., Thompson,S., Rahman,A., Yamashita,D.S., Xie,R., Ru,Y., Gress,C.J., Blake,S., Lark,M.A., Hwang,S.M., Tomaszek,T., Offen,P., Head,M.S., Cummings,M.D. and Veber,D.F.
    Azepanone-based inhibitors of human cathepsin L
    J Med Chem (3-11-2005) 48, 6870-6878. PubMed  Europe PubMed DOI  I
  406. Nishinaka,T., Song,J., Lum,K. and Chiu,R.
    Molecular cloning of cDNA for SPase, a monkey cathepsin L orthologue
    DNA Seq (2005) 16, 147-150. PubMed  Europe PubMed DOI
  407. Pager,C.T. and Dutch,R.E.
    Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein
    J Virol (2005) 79, 12714-12720. PubMed  Europe PubMed DOI  PMC  EPMC
  408. Puzer,L., Vercesi,J., Alves,M.F., Barros,N.M., Araujo,M.S., Aparecida Juliano,M., Reis,M.L., Juliano,L. and Carmona,A.K.
    A possible alternative mechanism of kinin generation in vivo by cathepsin L
    Biol Chem (2005) 386, 699-704. PubMed  Europe PubMed DOI
  409. [YEAR:1-8-2005]Reinheckel,T., Hagemann,S., Dollwet-Mack,S., Martinez,E., Lohmuller,T., Zlatkovic,G., Tobin,D.J., Maas-Szabowski,N. and Peters,C.
    The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling
    J Cell Sci (1-8-2005) 118, 3387-3395. PubMed  Europe PubMed DOI
  410. Rocken,C., Menard,R., Buhling,F., Vockler,S., Raynes,J., Stix,B., Kruger,S., Roessner,A. and Kahne,T.
    Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation
    Ann Rheum Dis (2005) 64, 808-815. PubMed  Europe PubMed DOI  PMC  EPMC
  411. [YEAR:4-8-2005]Simmons,G., Gosalia,D.N., Rennekamp,A.J., Reeves,J.D., Diamond,S.L. and Bates,P.
    Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
    Proc Natl Acad Sci U S A (4-8-2005) 102, 11876-11881. PubMed  Europe PubMed DOI  PMC  EPMC
  412. Urbich,C., Heeschen,C., Aicher,A., Sasaki,K., Bruhl,T., Farhadi,M.R., Vajkoczy,P., Hofmann,W.K., Peters,C., Pennacchio,L.A., Abolmaali,N.D., Chavakis,E., Reinheckel,T., Zeiher,A.M. and Dimmeler,S.
    Cathepsin L is required for endothelial progenitor cell-induced neovascularization
    Nat Med (2005) 11, 206-213. PubMed  Europe PubMed DOI
  413. 2004
  414. [YEAR:1-11-2004]Collette,J., Ulku,A.S., Der,C.J., Jones,A. and Erickson,A.H.
    Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells
    Int J Cancer (1-11-2004) 112, 190-199. PubMed  Europe PubMed DOI
  415. Collette,J., Bocock,J.P., Ahn,K., Chapman,R.L., Godbold,G., Yeyeodu,S. and Erickson,A.H.
    Biosynthesis and alternate targeting of the lysosomal cysteine protease cathepsin L
    Int Rev Cytol (2004) 241, 1-51. PubMed  Europe PubMed DOI
  416. [YEAR:16-8-2004]Goulet,B. and Nepveu,A.
    Complete and limited proteolysis in cell cycle progression
    Cell Cycle (16-8-2004) 3, 986-989. PubMed  Europe PubMed
  417. [YEAR:23-4-2004]Goulet,B., Baruch,A., Moon,N.S., Poirier,M., Sansregret,L.L., Erickson,A., Bogyo,M. and Nepveu,A.
    A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor
    Mol Cell (23-4-2004) 14, 207-219. PubMed  Europe PubMed DOI
  418. Hook,V., Yasothornsrikul,S., Greenbaum,D., Medzihradszky,K.F., Troutner,K., Toneff,T., Bundey,R., Logrinova,A., Reinheckel,T., Peters,C. and Bogyo,M.
    Cathepsin L and Arg/Lys aminopeptidase: a distinct prohormone processing pathway for the biosynthesis of peptide neurotransmitters and hormones
    Biol Chem (2004) 385, 473-480. PubMed  Europe PubMed DOI
  419. Hook,V.Y.H.
    Prohormone thiol protease
    [ISSN:0-12-079610-4] (2004) 2, 1408-1413.  V
  420. Hu,K.J. and Leung,P.C.
    Shrimp cathepsin L encoded by an intronless gene has predominant expression in hepatopancreas, and occurs in the nucleus of oocyte
    Comp Biochem Physiol B Biochem Mol Biol (2004) 137, 21-33. PubMed  Europe PubMed DOI
  421. Kirschke,H.
    Cathepsin L
    [ISSN:0-12-079610-4] (2004) 2, 1097-1102.  V
  422. Onishi,K., Li,Y., Ishii,K., Hisaeda,H., Tang,L., Duan,X., Dainichi,T., Maekawa,Y., Katunuma,N. and Himeno,K.
    Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection
    Microbes Infect (2004) 6, 468-474. PubMed  Europe PubMed DOI  I
  423. [YEAR:15-10-2004]Puzer,L., Cotrin,S.S., Alves,M.F., Egborge,T., Araujo,M.S., Juliano,M.A., Juliano,L., Bromme,D. and Carmona,A.K.
    Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L
    Arch Biochem Biophys (15-10-2004) 430, 274-283. PubMed  Europe PubMed DOI
  424. [YEAR:15-12-2004]Ravanko,K., Jarvinen,K., Helin,J., Kalkkinen,N. and Holtta,E.
    Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts
    Cancer Res (15-12-2004) 64, 8831-8838. PubMed  Europe PubMed DOI
  425. [YEAR:1-1-2004]Rousselet,N., Mills,L., Jean,D., Tellez,C., Bar-Eli,M. and Frade,R.
    Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment
    Cancer Res (1-1-2004) 64, 146-151. PubMed  Europe PubMed DOI
  426. Schedel,J., Seemayer,C.A., Pap,T., Neidhart,M., Kuchen,S., Michel,B.A., Gay,R.E., Muller-Ladner,U., Gay,S. and Zacharias,W.
    Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis
    Gene Ther (2004) 11, 1040-1047. PubMed  Europe PubMed DOI
  427. Sentandreu,M.A., Aubry,L. and Ouali,A.
    A rapid purification procedure for cathepsin L from bovine species and production of specific antibodies
    J Sci Food Agric (2004) 84, 2052-2060.
  428. [YEAR:22-11-2004]Soukenik,M., Diehl,A., Leidert,M., Sievert,V., Bussow,K., Leitner,D., Labudde,D., Ball,L.J., Lechner,A., Nagler,D.K. and Oschkinat,H.
    The SEP domain of p47 acts as a reversible competitive inhibitor of cathepsin L
    FEBS Lett (22-11-2004) 576, 358-362. PubMed  Europe PubMed DOI
  429. [YEAR:16-10-2004]Sriraman,V. and Richards,J.S.
    Cathepsin L gene expression and promoter activation in rodent granulosa cells
    Endocrinology (16-10-2004) 145, 582-591. PubMed  Europe PubMed DOI
  430. Wille,A., Gerber,A., Heimburg,A., Reisenauer,A., Peters,C., Saftig,P., Reinheckel,T., Welte,T. and Buhling,F.
    Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells
    Biol Chem (2004) 385, 665-670. PubMed  Europe PubMed DOI
  431. 2003
  432. [YEAR:20-1-2003]Beers,C., Honey,K., Fink,S., Forbush,K. and Rudensky,A.
    Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages
    J Exp Med (20-1-2003) 197, 169-179. PubMed  Europe PubMed DOI  PMC  EPMC
  433. Charron,M., Folmer,J.S. and Wright,W.W.
    A 3-kilobase region derived from the rat cathepsin L gene directs in vivo expression of a reporter gene in sertoli cells in a manner comparable to that of the endogenous gene
    Biol Reprod (2003) 68, 1641-1648. PubMed  Europe PubMed DOI
  434. Charron,M., DeCerbo,J.N. and Wright,W.W.
    A GC-box within the proximal promoter region of the rat cathepsin L gene activates transcription in Sertoli cells of sexually mature rats
    Biol Reprod (2003) 68, 1649-1656. PubMed  Europe PubMed DOI
  435. Desmazes,C., Galineau,L., Gauthier,F., Bromme,D. and Lalmanach,G.
    Kininogen-derived peptides for investigating the putative vasoactive properties of human cathepsins K and L
    Eur J Biochem (2003) 270, 171-178. PubMed  Europe PubMed DOI
  436. Levicar,N., Dewey,R.A., Daley,E., Bates,T.E., Davies,D., Kos,J., Pilkington,G.J. and Lah,T.T.
    Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis
    Cancer Gene Ther (2003) 10, 141-151. PubMed  Europe PubMed DOI  K
  437. [YEAR:26-6-2003]Ohashi,K., Naruto,M., Nakaki,T. and Sano,E.
    Identification of interleukin-8 converting enzyme as cathepsin L
    Biochim Biophys Acta (26-6-2003) 1649, 30-39. PubMed  Europe PubMed DOI
  438. [YEAR:4-12-2003]Seth,P., Mahajan,V.S. and Chauhan,S.S.
    Transcription of human cathepsin L mRNA species hCATL B from a novel alternative promoter in the first intron of its gene
    Gene (4-12-2003) 321, 83-91. PubMed  Europe PubMed DOI
  439. [YEAR:24-6-2003]Welss,T., Sun,J., Irving,J.A., Blum,R., Smith,A.I., Whisstock,J.C., Pike,R.N., von Mikecz,A., Ruzicka,T., Bird,P.I. and Abts,H.F.
    Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis
    Biochemistry (24-6-2003) 42, 7381-7389. PubMed  Europe PubMed DOI
  440. Wright,W.W., Smith,L., Kerr,C. and Charron,M.
    Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis
    Biol Reprod (2003) 68, 680-687. PubMed  Europe PubMed DOI
  441. [YEAR:5-8-2003]Yasothornsrikul,S., Greenbaum,D., Medzihradszky,K.F., Toneff,T., Bundey,R., Miller,R., Schilling,B., Petermann,I., Dehnert,J., Logvinova,A., Goldsmith,P., Neveu,J.M., Lane,W.S., Gibson,B., Reinheckel,T., Peters,C., Bogyo,M. and Hook,V.
    Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter
    Proc Natl Acad Sci U S A (5-8-2003) 100, 9590-9595. PubMed  Europe PubMed DOI  PMC  EPMC
  442. 2002
  443. [YEAR:26-6-2002]Arora,S. and Chauhan,S.S.
    Identification and characterization of a novel human cathepsin L splice variant
    Gene (26-6-2002) 293, 123-131. PubMed  Europe PubMed DOI  R
  444. Benavides,F., Starost,M.F., Flores,M., Gimenez-Conti,I.B., Guenet,J.L. and Conti,C.J.
    Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation
    Am J Pathol (2002) 161, 693-703. PubMed  Europe PubMed DOI  PMC  EPMC  K  M
  445. [YEAR:21-11-2002]Chowdhury,S.F., Sivaraman,J., Wang,J., Devanathan,G., Lachance,P., Qi,H., Menard,R., Lefebvre,J., Konishi,Y., Cygler,M., Sulea,T. and Purisima,E.O.
    Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides
    J Med Chem (21-11-2002) 45, 5321-5329. PubMed  Europe PubMed DOI  S  I
  446. [YEAR:5-7-2002]Ebert,D.H., Deussing,J., Peters,C. and Dermody,T.S.
    Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells
    J Biol Chem (5-7-2002) 277, 24609-24617. PubMed  Europe PubMed DOI
  447. [YEAR:11-6-2002]Felbor,U., Kessler,B., Mothes,W., Goebel,H.H., Ploegh,H.L., Bronson,R.T. and Olsen,B.R.
    Neuronal loss and brain atrophy in mice lacking cathepsins B and L
    Proc Natl Acad Sci U S A (11-6-2002) 99, 7883-7888. PubMed  Europe PubMed DOI  PMC  EPMC  K
  448. [YEAR:4-11-2002]Fiebiger,E., Maehr,R., Villadangos,J., Weber,E., Erickson,A., Bikoff,E., Ploegh,H.L. and Lennon-Dumenil,A.M.
    Invariant chain controls the activity of extracellular cathepsin L
    J Exp Med (4-11-2002) 196, 1263-1269. PubMed  Europe PubMed DOI  PMC  EPMC
  449. [YEAR:1-10-2002]Guillaume-Rousselet,N., Jean,D. and Frade,R.
    Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells
    Biochem J (1-10-2002) 367, 219-227. PubMed  Europe PubMed DOI  PMC  EPMC
  450. [YEAR:20-5-2002]Honey,K., Nakagawa,T., Peters,C. and Rudensky,A.
    Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands
    J Exp Med (20-5-2002) 195, 1349-1358. PubMed  Europe PubMed DOI  PMC  EPMC
  451. [YEAR:1-1-2002]Jean,D., Guillaume,N. and Frade,R.
    Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity
    Biochem J (1-1-2002) 361, 173-184. PubMed  Europe PubMed DOI  PMC  EPMC
  452. Nishimura,F., Naruishi,H., Naruishi,K., Yamada,T., Sasaki,J., Peters,C., Uchiyama,Y. and Murayama,Y.
    Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice
    Am J Pathol (2002) 161, 2047-2052. PubMed  Europe PubMed DOI  PMC  EPMC
  453. Siavash,H., Lopes,M., Norris,K., Hebert,C., Nikitakis,N. and Sauk,J.J.
    Inhibition of cysteine proteinases by autolytic digestion is mediated by CBP2/Hsp47
    Connect Tissue Res (2002) 43, 589-594. PubMed  Europe PubMed
  454. [YEAR:30-4-2002]Stypmann,J., Glaser,K., Roth,W., Tobin,D.J., Petermann,I., Matthias,R., Monnig,G., Haverkamp,W., Breithardt,G., Schmahl,W., Peters,C. and Reinheckel,T.
    Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L
    Proc Natl Acad Sci U S A (30-4-2002) 99, 6234-6239. PubMed  Europe PubMed DOI  PMC  EPMC  K
  455. Tobin,D.J., Foitzik,K., Reinheckel,T., Mecklenburg,L., Botchkarev,V.A., Peters,C. and Paus,R.
    The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling
    Am J Pathol (2002) 160, 1807-1821. PubMed  Europe PubMed DOI  PMC  EPMC
  456. [YEAR:1-11-2002]Warner,J.B., Thalhauser,C., Tao,K. and Sahagian,G.G.
    Role of N-linked oligosaccharide flexibility in mannose phosphorylation of lysosomal enzyme cathepsin L
    J Biol Chem (1-11-2002) 277, 41897-41905. PubMed  Europe PubMed DOI
  457. 2001
  458. Abudula,A., Rommerskirch,W., Weber,E., Gunther,D. and Wiederanders,B.
    Splice variants of human cathepsin L mRNA show different expression rates
    Biol Chem (2001) 382, 1583-1591. PubMed  Europe PubMed DOI  R
  459. [YEAR:5-9-2001]Bakhshi,R., Goel,A., Seth,P., Chhikara,P. and Chauhan,S.S.
    Cloning and characterization of human cathepsin L promoter
    Gene (5-9-2001) 275, 93-101. PubMed  Europe PubMed DOI
  460. Benavides,F., Venables,A., Poetschke Klug,H., Glasscock,E., Rudensky,A., Gomez,M., Martin Palenzuela,N., Guenet,J.L., Richie,E.R. and Conti,C.J.
    The CD4 T cell-deficient mouse mutation nackt (nkt) involves a deletion in the cathepsin L (Ctsl) gene
    Immunogenetics (2001) 53, 233-242. PubMed  Europe PubMed DOI
  461. Harrison,M.T. and McCoy,K.L.
    Immunosuppression by arsenic: a comparison of cathepsin L inhibition and apoptosis
    Int Immunopharmacol (2001) 1, 647-656. PubMed  Europe PubMed DOI
  462. [YEAR:22-6-2001]Honey,K., Duff,M., Beers,C., Brissette,W.H., Elliott,E.A., Peters,C., Maric,M., Cresswell,P. and Rudensky,A.
    Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes
    J Biol Chem (22-6-2001) 276, 22573-22578. PubMed  Europe PubMed DOI  K
  463. [YEAR:13-4-2001]James,I.E., Marquis,R.W., Blake,S.M., Hwang,S.M., Gress,C.J., Ru,Y., Zembryki,D., Yamashita,D.S., McQueney,M.S., Tomaszek,T.A., Oh,H.J., Gowen,M., Veber,D.F. and Lark,M.W.
    Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro
    J Biol Chem (13-4-2001) 276, 11507-11511. PubMed  Europe PubMed DOI  I
  464. Krueger,S., Kellner,U., Buehling,F. and Roessner,A.
    Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype
    Cancer Gene Ther (2001) 8, 522-528. PubMed  Europe PubMed DOI
  465. [YEAR:1-8-2001]Lennon-Dumenil,A.M., Roberts,R.A., Valentijn,K., Driessen,C., Overkleeft,H.S., Erickson,A., Peters,P.J., Bikoff,E., Ploegh,H.L. and Bryant,P.W.
    The p41 isoform of invariant chain is a chaperone for cathepsin L
    EMBO J (1-8-2001) 20, 4055-4064. PubMed  Europe PubMed DOI  PMC  EPMC
  466. [YEAR:1-6-2001]Melo,R.L., Alves,L.C., Del Nery,E., Juliano,L. and Juliano,M.A.
    Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides
    Anal Biochem (1-6-2001) 293, 71-77. PubMed  Europe PubMed DOI
  467. Reinheckel,T., Deussing,J., Roth,W. and Peters,C.
    Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L
    Biol Chem (2001) 382, 735-741. PubMed  Europe PubMed DOI  K
  468. Visessanguan,W., Menino,A.R., Kim,S.M. and An,H.
    Cathepsin L: A predominant heat-activated proteinase in arrowtooth flounder muscle
    J Agric Food Chem (2001) 49, 2633-2640. PubMed  Europe PubMed DOI
  469. 2000
  470. [YEAR:15-3-2000]Felbor,U., Dreier,L., Bryant,R.A., Ploegh,H.L., Olsen,B.R. and Mothes,W.
    Secreted cathepsin L generates endostatin from collagen XVIII
    EMBO J (15-3-2000) 19, 1187-1194. PubMed  Europe PubMed DOI  PMC  EPMC
  471. Guay,J., Falgueyret,J.P., Ducret,A., Percival,M.D. and Mancini,J.A.
    Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides
    Eur J Biochem (2000) 267, 6311-6318. PubMed  Europe PubMed DOI
  472. Jacobsen,W., Christians,U. and Benet,L.Z.
    In vitro evaluation of the disposition of a novel cysteine protease inhibitor
    Drug Metab Dispos (2000) 28, 1343-1351. PubMed  Europe PubMed  I
  473. Kirschke,H., Eerola,R., Hopsu-Havu,V.K., Bromme,D. and Vuorio,E.
    Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells
    Eur J Cancer (2000) 36, 787-795. PubMed  Europe PubMed DOI
  474. [YEAR:15-7-2000]Krupa,J.C. and Mort,J.S.
    Optimization of detergents for the assay of cathepsins B, L, S, and K
    Anal Biochem (15-7-2000) 283, 99-103. PubMed  Europe PubMed DOI  A
  475. [YEAR:7-8-2000]Lynas,J.F., Hawthorne,S.J. and Walker,B.
    Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L - comparisons of potency and selectivity profiles with cathepsin B
    Bioorg Med Chem Lett (7-8-2000) 10, 1771-1773. PubMed  Europe PubMed DOI  I
  476. [YEAR:1-4-2000]Portaro,F.C., Santos,A.B., Cezari,M.H., Juliano,M.A., Juliano,L. and Carmona,E.
    Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates
    Biochem J (1-4-2000) 347, 123-129. PubMed  Europe PubMed DOI  PMC  EPMC
  477. Roth,W., Deussing,J., Botchkarev,V.A., Pauly-Evers,M., Saftig,P., Hafner,A., Schmidt,P., Schmahl,W., Scherer,J., Anton-Lamprecht,I., von Figura,K., Paus,R. and Peters,C.
    Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling
    FASEB J (2000) 14, 2075-2086. PubMed  Europe PubMed DOI  K  M
  478. 1999
  479. Ando,R., Sakaki,T., Morinaka,Y., Takahashi,C., Tamao,Y., Yoshii,N., Katayama,S., Saito,K.I., Tokuyama,H., Isaka,M. and Nakamura,E.
    Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities
    Bioorg Med Chem (1999) 7, 571-579. PubMed  Europe PubMed  I
  480. Baer,G.S., Ebert,D.H., Chung,C.J., Erickson,A.H. and Dermody,T.S.
    Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly
    J Virol (1999) 73, 9532-9543. PubMed  Europe PubMed  PMC  EPMC
  481. [YEAR:15-2-1999]Guncar,G., Pungercic,G., Klemencic,I., Turk,V. and Turk,D.
    Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S
    EMBO J (15-2-1999) 18, 793-803. PubMed  Europe PubMed DOI  PMC  EPMC  S
  482. Hook,V.Y., Tezapsidis,N., Hwang,S.R., Sei,C., Byrne,M. and Yasothornsrikul,S.
    alpha1-Antichymotrypsin-like proteins I and II purified from bovine adrenal medulla are enriched in chromaffin granules and inhibit the proenkephalin processing enzyme "prohormone thiol protease"
    J Neurochem (1999) 73, 59-69. PubMed  Europe PubMed DOI
  483. [YEAR:10-9-1999]Katunuma,N., Murata,E., Kakegawa,H., Matsui,A., Tsuzuki,H., Tsuge,H., Turk,D., Turk,V., Fukushima,M., Tada,Y. and Asao,T.
    Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo
    FEBS Lett (10-9-1999) 458, 6-10. PubMed  Europe PubMed DOI  I
  484. Matsumoto,K., Mizoue,K., Kitamura,K., Tse,W.C., Huber,C.P. and Ishida,T.
    Structural basis of inhibition of cysteine proteases by E-64 and its derivatives
    Biopolymers (1999) 51, 99-107. PubMed  Europe PubMed DOI  I
  485. Ogino,T., Kaji,T., Kawabata,M., Satoh,K., Tomoo,K., Ishida,T., Yamazaki,H., Ishidoh,K. and Kominami,E.
    Function of the propeptide region in recombinant expression of active procathepsin L in Escherichia coli
    J Biochem (1999) 126, 78-83. PubMed  Europe PubMed  E
  486. [YEAR:16-7-1999]Popovic,T., Cimerman,N., Dolenc,I., Ritonja,A. and Brzin,J.
    Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids
    FEBS Lett (16-7-1999) 455, 92-96. PubMed  Europe PubMed DOI
  487. Werle,B., Staib,A., Julke,B., Ebert,W., Zladoidsky,P., Sekirnik,A., Kos,J. and Spiess,E.
    Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts
    Biol Chem (1999) 380, 1109-1116. PubMed  Europe PubMed DOI  A
  488. [YEAR:8-6-1999]Yasothornsrikul,S., Aaron,W., Toneff,T. and Hook,V.Y.
    Evidence for the proenkephalin processing enzyme prohormone thiol protease (PTP) as a multicatalytic cysteine protease complex: activation by glutathione localized to secretory vesicles
    Biochemistry (8-6-1999) 38, 7421-7430. PubMed  Europe PubMed DOI
  489. 1998
  490. [YEAR:18-9-1998]Le Boulay,C., Sellos,D. and Van Wormhoudt,A.
    Cathepsin L gene organization in crustaceans
    Gene (18-9-1998) 218, 77-84. PubMed  Europe PubMed DOI
  491. 1997
  492. Dalton,J.P., Clough,K.A., Jones,M.K. and Brindley,P.J.
    The cysteine proteinases of Schistosoma mansoni cercariae
    Parasitology (1997) 114, 105-112. PubMed  Europe PubMed DOI
  493. Fujishima,A., Imai,Y., Nomura,T., Fujisawa,Y., Yamamoto,Y. and Sugawara,T.
    The crystal structure of human cathepsin L complexed with E-64
    FEBS Lett (1997) 407, 47-50. PubMed  Europe PubMed DOI  S  I
  494. [YEAR:18-9-1997]Ishidoh,K., Taniguchi,S. and Kominami,E.
    Egr family member proteins are involved in the activation of the cathepsin L gene in v-src-transformed cells
    Biochem Biophys Res Commun (18-9-1997) 238, 665-669. PubMed  Europe PubMed DOI
  495. Matsumoto,I., Emori,Y., Abe,K. and Arai,S.
    Characterization of a gene family encoding cysteine proteinases of Sitophilus zeamais (maize weevil), and analysis of the protein distribution in various tissues including alimentary tract and germ cells
    J Biochem (1997) 121, 464-476. PubMed  Europe PubMed
  496. 1996
  497. Carmona,E., Dufour,E., Plouffe,C., Takebe,S., Mason,P., Mort,J.S. and Menard,R.
    Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases
    Biochemistry (1996) 35, 8149-8157. PubMed  Europe PubMed DOI
  498. Coulombe,R., Li,Y., Takebe,S., Menard,R., Mason,P., Mort,J.S. and Cygler,M.
    Crystallization and preliminary X-ray diffraction studies of human procathepsin L
    Proteins (1996) 25, 398-400. PubMed  Europe PubMed DOI  S
  499. Coulombe,R., Grochulski,P., Sivaraman,J., Menard,R., Mort,J.S. and Cygler,M.
    Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment
    EMBO J (1996) 15, 5492-5503. PubMed  Europe PubMed  PMC  EPMC  E  S
  500. Dalton,J.P., McGonigle,S., Rolph,T.P. and Andrews,S.J.
    Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin
    Infect Immun (1996) 64, 5066-5074. PubMed  Europe PubMed  PMC  EPMC
  501. Dalton,J.P., Clough,K.A., Jones,M.K. and Brindley,P.J.
    Characterization of the cathepsin-like cysteine proteinases of Schistosoma mansoni
    Infect Immun (1996) 64, 1328-1334. PubMed  Europe PubMed  PMC  EPMC
  502. Dehrmann,F.M., Elliott,E. and Dennison,C.
    Reductive activation markedly increases the stability of cathepsins B and L to extracellular ionic conditions
    Biol Chem Hoppe Seyler (1996) 377, 391-394. PubMed  Europe PubMed
  503. [YEAR:7-10-1996]Rescheleit,D.K., Rommerskirch,W.J. and Wiederanders,B.
    Sequence analysis and distribution of two new human cathepsin L splice variants
    FEBS Lett (7-10-1996) 394, 345-348. PubMed  Europe PubMed DOI  R
  504. Ritonja,A., Coetzer,T.H., Pike,R.N. and Dennison,C.
    The amino acid sequences, structure comparisons and inhibition kinetics of sheep cathepsin L and sheep stefin B
    Comp Biochem Physiol B Biochem Mol Biol (1996) 114, 193-198. PubMed  Europe PubMed DOI
  505. Volkel,H., Kurz,U., Linder,J., Klumpp,S., Gnau,V., Jung,G. and Schultz,J.E.
    Cathepsin L is an intracellular and extracellular protease in Paramecium tetraurelia. Purification, cloning, sequencing and specific inhibition by its expressed propeptide
    Eur J Biochem (1996) 238, 198-206. PubMed  Europe PubMed
  506. 1995
  507. Dolinar,M., Maganja,D.B. and Turk,V.
    Expression of full-length human procathepsin L cDNA in Escherichia coli and refolding of the expression product
    Biol Chem Hoppe Seyler (1995) 376, 385-388. PubMed  Europe PubMed  E
  508. Kawada,A., Hara,K., Hiruma,M., Noguchi,H. and Ishibashi,A.
    Rat epidermal cathepsin L-like proteinase: Purification and some hydrolytic properties toward filaggrin and synthetic substrates
    J Biochem (1995) 118, 332-337. PubMed  Europe PubMed
  509. [YEAR:4-8-1995]Martichonok,V., Plouffe,C., Storer,A.C., Menard,R. and Jones,J.B.
    Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases
    J Med Chem (4-8-1995) 38, 3078-3085. PubMed  Europe PubMed  I
  510. McDonald,J.K. and Emerick,J.M.
    Purification and characterization of procathepsin L, a self-processing zymogen of guinea pig spermatozoa that acts on a cathepsin D assay substrate
    Arch Biochem Biophys (1995) 323, 409-422. PubMed  Europe PubMed DOI  A
  511. Takeda,A., Yamamoto,T., Nakamura,Y., Takahashi,T. and Hibino,T.
    Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L
    FEBS Lett (1995) 359, 78-80. PubMed  Europe PubMed DOI
  512. Werle,B., Ebert,W., Klein,W. and Spiess,E.
    Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue
    Biol Chem Hoppe Seyler (1995) 376, 157-164. PubMed  Europe PubMed  I
  513. 1994
  514. Bromme,D., Bonneau,P.R., Lachance,P. and Storer,A.C.
    Engineering the S2 subsite specificity of human cathepsin S to a cathepsin L- and cathepsin B-like specificity
    J Biol Chem (1994) 269, 30238-30242. PubMed  Europe PubMed
  515. [YEAR:1-7-1994]Dowd,A.J., Smith,A.M., McGonigle,S. and Dalton,J.P.
    Purification and characterisation of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica
    Eur J Biochem (1-7-1994) 223, 91-98. PubMed  Europe PubMed DOI
  516. Gour-Salin,B.J., Lachance,P., Bonneau,P.R., Storer,A.C., Kirschke,H. and Bromme,D.
    E-64 analogs as inhibitors of cathepsin L and cathepsin S: importance of the S2-P2 interactions for potency and selectivity
    Bioorg Chem (1994) 22, 227-241.  I
  517. Kirschke,H. and Wiederanders,B.
    Cathepsin S and related lysosomal endopeptidases
    Methods Enzymol (1994) 244, 500-511. PubMed  Europe PubMed DOI  V
  518. [YEAR:15-5-1994]Tao,K., Stearns,N.A., Dong,J., Wu,Q.L. and Sahagian,G.G.
    The proregion of cathepsin L is required for proper folding, stability, and ER exit
    Arch Biochem Biophys (15-5-1994) 311, 19-27. PubMed  Europe PubMed DOI
  519. 1993
  520. [YEAR:25-9-1993]Hook,V.Y., Purviance,R.T., Azaryan,A.V., Hubbard,G. and Krieger,T.J.
    Purification and characterization of alpha 1-antichymotrypsin-like protease inhibitor that regulates prohormone thiol protease involved in enkephalin precursor processing
    J Biol Chem (25-9-1993) 268, 20570-20577. PubMed  Europe PubMed
  521. [YEAR:3-5-1993]Ishidoh,K., Takeda-Ezaki,M. and Kominami,E.
    Procathepsin L-specific antibodies that recognize procathepsin L but not cathepsin L
    FEBS Lett (3-5-1993) 322, 79-82. PubMed  Europe PubMed DOI
  522. Kane,S.E.
    Mouse procathepsin L lacking a functional glycosylation site is properly folded, stable, and secreted by NIH 3T3 cells
    J Biol Chem (1993) 268, 11456-11462. PubMed  Europe PubMed
  523. Menard,R., Carmona,E., Plouffe,C., Bromme,D., Konishi,Y., Lefebvre,J. and Storer,A.C.
    The specificity of the S1' subsite of cysteine proteases
    FEBS Lett (1993) 328, 107-110. PubMed  Europe PubMed DOI
  524. 1992
  525. Dolenc,I., Ritonja,A., Colic,A., Podobnik,M., Ogrinc,T. and Turk,V.
    Bovine cathepsins S and L: isolation and amino acid sequences
    Biol Chem Hoppe Seyler (1992) 373, 407-412. PubMed  Europe PubMed
  526. Pike,R.N., Coetzer,T.H. and Dennison,C.
    Proteolytically active complexes of cathepsin L and a cysteine proteinase inhibitor; purification and demonstration of their formation in vitro
    Arch Biochem Biophys (1992) 294, 623-629. PubMed  Europe PubMed DOI
  527. 1991
  528. Ritonja,A., Colic,A., Dolenc,I., Ogrinc,T., Podobnik,M. and Turk,V.
    The complete amino acid sequence of bovine cathepsin S and a partial sequence of bovine cathepsin L
    FEBS Lett (1991) 283, 329-331. PubMed  Europe PubMed DOI
  529. Tchoupe,J.R., Moreau,T., Gauthier,F. and Bieth,J.G.
    Photometric or fluorometric assay of cathepsin B, L and H and papain using substrates with an aminotrifluoromethylcoumarin leaving group
    Biochim Biophys Acta (1991) 1076, 149-151. PubMed  Europe PubMed DOI  A
  530. 1990
  531. Nguyen,Q., Mort,J.S. and Roughley,P.J.
    Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B
    Biochem J (1990) 266, 569-573. PubMed  Europe PubMed  PMC  EPMC
  532. Stearns,N.A., Dong,J.M., Pan,J.X., Brenner,D.A. and Sahagian,G.G.
    Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels
    Arch Biochem Biophys (1990) 283, 447-457. PubMed  Europe PubMed DOI
  533. 1989
  534. Fan,Y.S., Byers,M.G., Eddy,R.L., Joseph,L., Sukhatme,V., Chan,S.J. and Shows,T.B.
    Cathepsin L (CTSL) is located in the chromosome 9q21-q22 region; a related sequence is located on chromosome 10
    Cytogenet Cell Genet (1989) 51, 996-996.
  535. Mason,R.W., Wilcox,D., Wikstrom,P. and Shaw,E.N.
    The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor
    Biochem J (1989) 257, 125-129. PubMed  Europe PubMed  PMC  EPMC
  536. Pike,R. and Dennison,C.
    A high yield method for the isolation of sheep's liver cathepsin L
    Prep Biochem (1989) 19, 231-245. PubMed  Europe PubMed DOI
  537. [YEAR:16-10-1989]Rozhin,J., Wade,R.L., Honn,K.V. and Sloane,B.F.
    Membrane-associated cathepsin L: a role in metastasis of melanomas
    Biochem Biophys Res Commun (16-10-1989) 164, 556-561. PubMed  Europe PubMed
  538. Smith,S.M. and Gottesman,M.M.
    Activity and deletion analysis of recombinant human cathepsin L expressed in Escherichia coli
    J Biol Chem (1989) 264, 20487-20495. PubMed  Europe PubMed  E
  539. [YEAR:1-8-1989]Wiederanders,B. and Kirschke,H.
    The processing of a cathepsin L precursor in vitro
    Arch Biochem Biophys (1-8-1989) 272, 516-521. PubMed  Europe PubMed
  540. 1988
  541. Crawford,C., Mason,R.W., Wikstrom,P. and Shaw,E.
    The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B
    Biochem J (1988) 253, 751-758. PubMed  Europe PubMed  PMC  EPMC  I
  542. Hiwasa,T., Sakiyama,S., Yokoyama,S., Ha,J.M., Fujita,J., Noguchi,S., Bando,Y., Kominami,E. and Katunuma,N.
    Inhibition of cathepsin L-induced degradation of epidermal growth factor receptors by c-Ha-ras gene products
    Biochem Biophys Res Commun (1988) 151, 78-85. PubMed  Europe PubMed
  543. Joseph,L.J., Chang,L.C., Stamenkovich,D. and Sukhatme,V.P.
    Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts
    J Clin Invest (1988) 81, 1621-1629. PubMed  Europe PubMed DOI  PMC  EPMC
  544. Ritonja,A., Popovic,T., Kotnik,M., Machleidt,W. and Turk,V.
    Amino acid sequences of the human kidney cathepsins H and L
    FEBS Lett (1988) 228, 341-345. PubMed  Europe PubMed
  545. 1987
  546. Dufour,E., Obled,A., Valin,C., Bechet,D., Ribadeau-Dumas,B. and Huet,J.C.
    Purification and amino acid sequence of chicken liver cathepsin L
    Biochemistry (1987) 26, 5689-5695. PubMed  Europe PubMed
  547. 1986
  548. Gal,S. and Gottesman,M.M.
    The major excreted protein (MEP) of transformed mouse cells and cathepsin L have similar protease specificity
    Biochem Biophys Res Commun (1986) 139, 156-162. PubMed  Europe PubMed  P
  549. Johnson,D.A., Barrett,A.J. and Mason,R.W.
    Cathepsin L inactivates alpha1-proteinase inhibitor by cleavage in the reactive site region
    J Biol Chem (1986) 261, 14748-14751. PubMed  Europe PubMed
  550. Kirschke,H., Schmidt,I. and Wiederanders,B.
    Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15)
    Biochem J (1986) 240, 455-459. PubMed  Europe PubMed  PMC  EPMC
  551. 1985
  552. Etherington,D.J., Maciewicz,R.A., Mason,R.W., Taylor,M.A. and Wardale,R.J.
    A comparative study of cathepsins N and L and their distribution in different tissues
    Prog Clin Biol Res (1985) 180, 223-224. PubMed  Europe PubMed
  553. Mason,R.W., Green,G.D. and Barrett,A.J.
    Human liver cathepsin L
    Biochem J (1985) 226, 233-241. PubMed  Europe PubMed  PMC  EPMC
  554. 1984
  555. Hook,V.Y. and Loh,Y.P.
    Carboxypeptidase B-like converting enzyme activity in secretory granules of rat pituitary
    Proc Natl Acad Sci U S A (1984) 81, 2776-2780. PubMed  Europe PubMed  PMC  EPMC  I
  556. 1982
  557. [YEAR:22-2-1982]Pagano,M. and Engler,R.
    Inhibition of human liver cathepsin L by alpha-thiol proteinase inhibitor
    FEBS Lett (22-2-1982) 138, 307-310. PubMed  Europe PubMed
  558. 1981
  559. Barrett,A.J. and Kirschke,H.
    Cathepsin B, cathepsin H and cathepsin L
    Methods Enzymol (1981) 80, 535-561. PubMed  Europe PubMed DOI  V
  560. [YEAR:17-3-1981]Gottesman,M.M. and Cabral,F.
    Purification and characterization of a transformation-dependent protein secreted by cultured murine fibroblasts
    Biochemistry (17-3-1981) 20, 1659-1665. PubMed  Europe PubMed
  561. Kargel,H.J., Dettmer,R., Etzold,G., Kirschke,H., Bohley,P. and Langner,J.
    Action of rat liver cathepsin L on glucagon
    Acta Biol Med Ger (1981) 40, 1139-1143. PubMed  Europe PubMed
  562. 1980
  563. [YEAR:28-3-1980]Hibino,T., Fukuyama,K. and Epstein,W.L.
    In vitro and in vivo inhibition of rat liver cathepsin L by epidermal proteinase inhibitor
    Biochem Biophys Res Commun (28-3-1980) 93, 440-447. PubMed  Europe PubMed
  564. Kargel,H.J., Dettmer,R., Etzold,G., Kirschke,H., Bohley,P. and Langner,J.
    Action of cathepsin L on the oxidized B-chain of bovine insulin
    FEBS Lett (1980) 114, 257-260. PubMed  Europe PubMed
  565. 1978
  566. Gottesman,M.M.
    Transformation-dependent secretion of a low molecular weight protein by murine fibroblasts
    Proc Natl Acad Sci U S A (1978) 75, 2767-2771. PubMed  Europe PubMed  PMC  EPMC
  567. 1976
  568. Kirschke,H., Langner,J., Wiederanders,B., Ansorge,S., Bohley,P. and Broghammer,U.
    [Intracellular protein breakdown. VII. Cathepsin L and H; two new proteinases from rat liver lysosomes]
    Acta Biol Med Ger (1976) 35, 285-299. PubMed  Europe PubMed